Atlassian (TEAM) 10-Q 3 Feb 23 2023 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Dec. 31, 2022	Feb. 02, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2022
Document Transition Report	false
Entity File Number	001-37651
Entity Registrant Name	Atlassian Corporation
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	88-3940934
Entity Address, Address Line One	350 Bush Street
Entity Address, Address Line Two	Floor 13
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94104
City Area Code	415
Local Phone Number	701-1110
Title of 12(b) Security	Class A Common Stock, par value $0.00001 per share
Trading Symbol	TEAM
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001650372
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Amendment Flag	false
Class A
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		150,107,805
Class B
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		106,179,557

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2022	Jun. 30, 2022
Current assets
Cash and cash equivalents	$ 1,636,615	$ 1,385,265
Marketable securities	36,069	73,294
Accounts receivable, net	354,844	308,127
Assets held for sale	0	60,265
Prepaid expenses and other current assets	107,232	70,002
Total current assets	2,134,760	1,896,953
Non-current assets
Property and equipment, net	100,334	100,662
Operating lease right-of-use assets	254,811	277,276
Strategic investments	237,181	159,064
Intangible assets, net	84,248	100,840
Goodwill	723,229	722,838
Deferred tax assets	7,657	10,335
Other non-current assets	71,795	58,862
Total assets	3,614,015	3,326,830
Current liabilities
Accounts payable	130,318	81,220
Accrued expenses and other current liabilities	308,930	406,139
Deferred revenue, current portion	1,158,743	1,066,059
Operating lease liabilities, current portion	46,659	40,638
Total current liabilities	1,644,650	1,594,056
Non-current liabilities
Deferred revenue, net of current portion	115,338	116,621
Operating lease liabilities, net of current portion	257,653	274,434
Term loan facility	999,506	999,419
Deferred tax liabilities	2,489	312
Other non-current liabilities	16,887	14,616
Total liabilities	3,036,523	2,999,458
Commitments and contingencies
Stockholders' equity
Additional paid-in capital	2,621,776	2,182,536
Accumulated other comprehensive income	43,516	13,864
Accumulated deficit	(2,087,802)	(1,869,030)
Total stockholders’ equity	577,492	327,372
Total liabilities and stockholders’ equity	3,614,015	3,326,830
Class A
Stockholders' equity
Common stock, value issued	1	1
Class B
Stockholders' equity
Common stock, value issued	$ 1	$ 1

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2022	Jun. 30, 2022
Class A
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	750,000,000	750,000,000
Common stock, shares issued (in shares)	149,039,165	144,891,749
Common stock, shares outstanding (in shares)	149,039,165	144,891,749
Class B
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	230,000,000	230,000,000
Common stock, shares issued (in shares)	107,247,693	110,035,649
Common stock, shares outstanding (in shares)	107,247,693	110,035,649

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022		Dec. 31, 2021
Revenues:
Total revenues	$ 872,704	$ 688,526	$ 1,680,096		$ 1,302,550
Cost of revenues	155,945	110,191	295,337	[1],[2]	206,447	[1],[2]
Gross profit	716,759	578,335	1,384,759		1,096,103
Operating expenses:
Research and development	473,676	318,569	872,682	[1],[2]	590,709	[1],[2]
Marketing and sales	186,191	121,046	346,319	[1],[2]	220,375	[1],[2]
General and administrative	156,131	115,678	299,024	[2]	205,500	[2]
Total operating expenses	815,998	555,293	1,518,025		1,016,584
Operating income (loss)	(99,239)	23,042	(133,266)		79,519
Other income (expense), net	(6,749)	(22,343)	22,540		(478,147)
Interest income	8,963	74	14,106		351
Interest expense	(7,508)	(21,022)	(13,629)		(32,540)
Loss before income taxes	(104,533)	(20,249)	(110,249)		(430,817)
Provision for income taxes	(100,498)	(2,079)	(108,523)		(2,715)
Net loss	$ (205,031)	$ (22,328)	$ (218,772)		$ (433,532)
Net loss per share:
Basic (in dollars per share)	$ (0.80)	$ (0.09)	$ (0.86)		$ (1.72)
Diluted (in dollars per share)	$ (0.80)	$ (0.09)	$ (0.86)		$ (1.72)
Weighted-average shares used in computing net loss per share:
Basic (in shares)	255,874,000	252,960,000	255,520,000		252,533,000
Diluted (in shares)	255,874,000	252,960,000	255,520,000		252,533,000
Subscription
Revenues:
Total revenues	$ 711,199	$ 508,987	$ 1,362,183		$ 944,283
Maintenance
Revenues:
Total revenues	106,023	127,059	219,588		257,649
Other
Revenues:
Total revenues	$ 55,482	$ 52,480	$ 98,325		$ 100,618
[1]Amounts include amortization of acquired intangible assets, as follows: Cost of revenues $ 5,697 $ 5,599 $ 11,394 $ 11,288 Research and development 93 93 187 187 Marketing and sales 2,506 2,266 5,011 4,537 Cost of revenues $ 18,553 $ 8,453 $ 29,166 $ 14,370 Research and development 169,342 90,120 279,471 154,402 Marketing and sales 38,156 21,873 61,351 36,367 General and administrative 39,734 25,374 69,428 41,588

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Amortization expense for intangible assets	$ 8,300	$ 8,000	$ 16,600	$ 16,000
Cost of revenues
Stock based compensation expense	18,553	8,453	29,166	14,370
Amortization expense for intangible assets	5,697	5,599	11,394	11,288
Research and development
Stock based compensation expense	169,342	90,120	279,471	154,402
Amortization expense for intangible assets	93	93	187	187
Marketing and sales
Stock based compensation expense	38,156	21,873	61,351	36,367
Amortization expense for intangible assets	2,506	2,266	5,011	4,537
General and administrative
Stock based compensation expense	$ 39,734	$ 25,374	$ 69,428	$ 41,588

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (205,031)	$ (22,328)	$ (218,772)	$ (433,532)
Other comprehensive income (loss), net of reclassification adjustments:
Foreign currency translation adjustment	6,285	(2,832)	(4,292)	(6,162)
Net change in unrealized gains (losses) on marketable and privately held debt securities	1,085	(175)	1,220	(1,372)
Net gain on cash flow hedging derivative instruments	28,755	13,127	32,724	366
Other comprehensive income (loss), before tax	36,125	10,120	29,652	(7,168)
Income tax effect	0	2	0	134
Other comprehensive income (loss), net of tax	36,125	10,122	29,652	(7,034)
Total comprehensive loss, net of tax	$ (168,906)	$ (12,206)	$ (189,120)	$ (440,566)

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Class A	Class B	Common Stock Class A	Common Stock Class B	Additional paid in capital	Accumulated other comprehensive income	Accumulated Deficit
Shares, beginning balance (in shares) at Jun. 30, 2021				137,038,000	114,610,000
Beginning balance at Jun. 30, 2021	$ 313,262			$ 1	$ 1	$ 1,657,426	$ 5,354	$ (1,349,520)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued under employee stock plans (in shares)				1,706,000
Common stock issued under employee stock plans	5					5
Conversion from Class B common stock to class A common stock (in shares)				2,277,000	(2,277,000)
Stock-based compensation	246,826					246,826
Other comprehensive loss, net of tax	(7,034)						(7,034)
Net loss	(433,532)	$ (239,710)	$ (193,822)					(433,532)
Shares, ending balance (in shares) at Dec. 31, 2021				141,021,000	112,333,000
Ending balance at Dec. 31, 2021	119,527			$ 1	$ 1	1,904,257	(1,680)	(1,783,052)
Shares, beginning balance (in shares) at Sep. 30, 2021				139,089,000	113,471,000
Beginning balance at Sep. 30, 2021	(14,153)			$ 1	$ 1	1,758,371	(11,802)	(1,760,724)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued under employee stock plans (in shares)				794,000
Common stock issued under employee stock plans	4					4
Conversion from Class B common stock to class A common stock (in shares)				1,138,000	(1,138,000)
Stock-based compensation	145,882					145,882
Other comprehensive loss, net of tax	10,122						10,122
Net loss	(22,328)	$ (12,413)	$ (9,915)					(22,328)
Shares, ending balance (in shares) at Dec. 31, 2021				141,021,000	112,333,000
Ending balance at Dec. 31, 2021	119,527			$ 1	$ 1	1,904,257	(1,680)	(1,783,052)
Shares, beginning balance (in shares) at Jun. 30, 2022		144,891,749	110,035,649	144,820,000	110,036,000
Beginning balance at Jun. 30, 2022	327,372			$ 1	$ 1	2,182,536	13,864	(1,869,030)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued under employee stock plans (in shares)				1,412,000
Common stock issued under employee stock plans	(176)					(176)
Conversion from Class B common stock to class A common stock (in shares)				2,788,000	(2,788,000)
Stock-based compensation	439,416					439,416
Other comprehensive loss, net of tax	29,652						29,652
Net loss	(218,772)	$ (126,357)	$ (92,415)					(218,772)
Shares, ending balance (in shares) at Dec. 31, 2022		149,039,165	107,247,693	149,020,000	107,248,000
Ending balance at Dec. 31, 2022	577,492			$ 1	$ 1	2,621,776	43,516	(2,087,802)
Shares, beginning balance (in shares) at Sep. 30, 2022				148,232,000	107,248,000
Beginning balance at Sep. 30, 2022	480,613			$ 1	$ 1	2,355,991	7,391	(1,882,771)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued under employee stock plans (in shares)				788,000
Stock-based compensation	265,785					265,785
Other comprehensive loss, net of tax	36,125						36,125
Net loss	(205,031)	$ (119,094)	$ (85,937)					(205,031)
Shares, ending balance (in shares) at Dec. 31, 2022		149,039,165	107,247,693	149,020,000	107,248,000
Ending balance at Dec. 31, 2022	$ 577,492			$ 1	$ 1	$ 2,621,776	$ 43,516	$ (2,087,802)

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ (205,031)	$ (22,328)	$ (218,772)	$ (433,532)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	15,476	12,298	30,096	25,602
Stock-based compensation	265,785	145,820	439,416	246,727
Deferred income taxes	3,291	(427)	4,813	(2,041)
Net loss on exchange derivative and capped call transactions	0	0	0	424,482
Amortization of debt discount and issuance cost	117	16,975	235	26,816
Net loss on strategic investments	7,563	22,135	19,076	53,557
Net foreign currency gain	(2,203)	(5,258)	(5,828)	(11,656)
Gain on a non-cash sale of a controlling interest of a subsidiary	(2,066)	0	(45,158)	0
Other	(5)	297	(5)	(318)
Changes in operating assets and liabilities:
Accounts receivable, net	(107,805)	(54,992)	(46,491)	(68,203)
Prepaid expenses and other assets	(2,690)	(3,897)	(25,367)	(25,082)
Accounts payable	18,587	10,284	49,734	20,507
Accrued expenses and other liabilities	58,260	21,119	(50,183)	(63,287)
Deferred revenue	101,246	64,429	91,401	77,884
Net cash provided by operating activities	150,525	206,455	242,967	271,456
Cash flows from Investing activities:
Business combinations, net of cash acquired	0	(2,701)	(600)	(3,839)
Purchases of property and equipment	(4,040)	(12,581)	(20,536)	(19,462)
Purchases of strategic investments	(1,100)	(42,000)	(9,450)	(95,000)
Purchases of marketable securities	0	0	(10,000)	(21,003)
Proceeds from maturities of marketable securities	18,750	7,600	47,700	61,487
Proceeds from sales of marketable securities and strategic investments	363	0	621	186,262
Net cash provided by (used in) investing activities	13,973	(49,682)	7,735	108,445
Cash flows from financing activities:
Proceeds from term loan facility	0	350,000	0	1,000,000
Repayment of exchangeable senior notes	0	(1,234,376)	0	(1,548,686)
Proceeds from settlement of capped call transactions	0	104,519	0	135,497
Proceeds from other financing arrangements	0	4	1,396	5
Net cash provided by (used in) financing activities	0	(779,853)	1,396	(413,184)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash	3,522	(246)	(1,417)	(2,355)
Net increase (decrease) in cash, cash equivalents, and restricted cash	168,020	(623,326)	250,681	(35,638)
Cash, cash equivalents, and restricted cash at beginning of period	1,469,949	1,519,213	1,386,686	931,023
Net decrease in cash and cash equivalents included in assets held for sale	0	4,182	602	4,684
Cash, cash equivalents, and restricted cash at end of period	1,637,969	900,069	1,637,969	900,069
Reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above:
Cash and cash equivalents			1,385,265
Restricted cash included in other non-current assets	1,354	675	1,354	675
Total cash, cash equivalents, and restricted cash	1,637,969	900,069	1,637,969	900,069
Supplemental disclosures of cash flow information:
Income taxes paid, net of refunds	63,742	42,611	92,962	53,941
Interest paid	6,813	3,603	12,388	4,802
Non-cash investing and financing activities:
Purchase of property and equipment included in accrued expenses and other current liabilities	$ 1,385	$ 5,062	$ 1,385	$ 5,062

Description of Business

Description of Business	6 Months Ended
	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business	Description of Business Atlassian Corporation, a Delaware corporation, designs, develops, licenses, and maintains software and provisions software hosting services to help teams organize, discuss, and complete their work. Our primary products include Jira Software and Jira Work Management for planning and project management, Confluence for content creation and sharing, Trello for capturing and adding structure to fluid, fast-forming work for teams, Jira Service Management for team service, management, and support applications, Jira Align for enterprise agile planning, and Bitbucket for code sharing and management. The Company is the successor parent entity to Atlassian Corporation Plc, which was a public company limited by shares, incorporated under the laws of England and Wales. The Company’s fiscal year ends on June 30 of each year. References to fiscal year 2023, for example, refer to the fiscal year ending June 30, 2023. On September 30, 2022, the Company completed the U.S. Domestication to change its publicly traded parent company from a company incorporated under the laws of England and Wales to a Delaware corporation. Atlassian Corporation Plc’s stockholders and the High Court of Justice of England and Wales approved the scheme of arrangement effecting the U.S. Domestication. Effective after the close of market trading on September 30, 2022, all issued and outstanding ordinary shares of Atlassian Corporation Plc were exchanged on a one-for-one basis for newly issued shares of corresponding common stock of Atlassian Corporation, and all issued and outstanding equity awards of Atlassian Corporation Plc were assumed by Atlassian Corporation and were converted into rights to acquire Atlassian Corporation shares of Class A Common Stock on the same terms. The Class A Common Stock of Atlassian Corporation began trading on October 3, 2022 (the first trading day following the U.S. Domestication), and the Company’s trading symbol on The Nasdaq Global Select Market remained unchanged as “TEAM.”

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Preparation The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). These principles are established primarily by the Financial Accounting Standards Board (“FASB”). Due to rounding, numbers presented throughout this document may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures. The accompanying condensed consolidated financial statements contain all normal recurring adjustments which are necessary to fairly present the condensed consolidated balance sheets as of December 31, 2022 and June 30, 2022, the statements of operation, comprehensive loss, stockholders’ equity, and cash flows for the three and six months ended December 31, 2022 and 2021. These condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures made are sufficient to make the information not misleading . Results of operations for interim periods are not necessarily indicative of results for the entire year or of the results to be expected in future periods. Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions in the Company’s condensed consolidated financial statements. These estimates are based on information available as of the date of the condensed consolidated financial statements. On a regular basis, management evaluates these estimates and assumptions. Such management estimates and assumptions include, but are not limited to, revenue recognition, useful lives and impairment of long-lived assets, valuation of intangible assets, fair value measurement of financial instruments and income taxes. Actual results could differ materially from these estimates. Segment The Company operates as a single operating segment. An operating segment is defined as a component of an entity for which discrete financial information is available and whose results of operations are regularly reviewed by the chief operating decision maker (“CODM”). The Company’s CODMs are its Co-Chief Executive Officers, who review its results of operations to make decisions about allocating resources and assessing performance based on consolidated financial information. Accordingly, the Company has determined it operates as a single operating and reportable segment. Foreign Currency The Company’s condensed consolidated financial statements are presented using the U.S. dollar, which is its reporting currency. The functional currency for certain of our foreign subsidiaries is the U.S. dollar, while others use local currencies. The Company translates the foreign functional currency financial statements to U.S. dollars for those entities that do not have the U.S. dollar as their functional currency using the exchange rates at the balance sheet date for assets and liabilities, the period average exchange rates for revenues and expenses, and the historical exchange rates for equity transactions. The effects of foreign currency translation adjustments are recorded in accumulated other comprehensive income in the condensed consolidated statements of comprehensive loss. Foreign currency transaction gains and losses are included in other income (expense), net on the condensed consolidated statements of operations. Revenue Recognition Policies, Estimates and Judgments Revenues are generally recognized upon the transfer of control of promised products or services provided to customers, reflecting the amount of consideration the Company expects to receive for those products or services. The Company enters into contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. Revenue is recognized net of sales and other similar taxes collected from customers, which are subsequently remitted to governmental authorities. Revenues are recognized upon the application of the following steps: 1. Identification of the contract or contracts with a customer; 2. Identification of the performance obligations in the contract; 3. Determination of the transaction price; 4. Allocation of the transaction price to the performance obligations in the contract; and 5. Recognition of revenue when, or as, the performance obligation is satisfied. The timing of revenue recognition may differ from the timing of billing our customers. The Company receives payments from customers based on a billing schedule as established in its contracts. Contract assets are recognized when performance is completed in advance of billings. Deferred revenue is recorded when billings are in advance of performance under the contract. The Company’s revenue arrangements include standard warranty provisions that the products and services will perform and operate in all material respects with the applicable published specifications, the financial impacts of which have historically been and are expected to continue to be insignificant. The Company’s contracts do not include a significant financing component. Customer contracts often include promises to transfer multiple products and services to a customer. Determining whether products and services are considered distinct performance obligations that should be accounted for separately versus together may require judgment. The Company allocates the transaction price for each contract to each performance obligation based on the relative standalone selling price (“SSP”) for each distinct performance obligation. Judgment is required in determining the SSP for each distinct performance obligation. The Company typically determines an SSP range for its products and services, which is reassessed on a periodic basis or when facts and circumstances change. In most cases, the Company is able to determine SSP based on the observable prices of products or services sold separately in comparable circumstances to similar customers. In instances where performance obligations do not have observable standalone sales, the Company utilizes available information that may include market conditions, pricing strategies, the economic life of the software, and other observable inputs to estimate the price that it would charge if the products and services were sold separately. Products are generally sold with a right of return and may include other credits or incentives, and, in certain instances, the Company may estimate customer usage of its services, which are accounted for as variable consideration when determining the amount of revenue to recognize. Returns and credits are estimated at contract inception and updated at the end of each reporting period if additional information becomes available. Variable consideration was not material for the periods presented. Recognition of Revenue Revenue recognized from contracts with customers is disaggregated into categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. The Company reports revenues in three categories: (i) subscription, (ii) maintenance, and (iii) other. In addition, revenue is presented by geographic region and deployment option in Note 14, “ Revenue. ” Subscription Revenues Subscription revenues consist primarily of fees earned from subscription-based arrangements for providing customers the right to use our software in a cloud-based-infrastructure that the Company provides. The Company also sells on-premises term license agreements for its data center products, which are software licensed for a specified period, and includes support and maintenance service that is bundled with the license for the term of the license period. Subscription revenues are driven primarily by the number and size of active licenses, the type of product and the price of the licenses. Subscription-based arrangements generally have a contractual term of one Maintenance Revenues Maintenance revenues represent fees earned from providing customers with unspecified future updates, upgrades and enhancements and technical product support for perpetual license products on an if-and-when-available basis. Maintenance revenue is recognized ratably over the term of the support period. Other Revenues Other revenues primarily include perpetual license revenue and fees received for sales of third-party apps in the Atlassian Marketplace. Technical account management, consulting and training services are also included in other revenues. Perpetual license revenues represent fees earned from the license of software to customers for use on the customer’s premises other than data center products. Software is licensed on a perpetual basis. Perpetual license revenues consist of the revenues recognized from sales of licenses to customers. The Company no longer sells perpetual licenses or upgrades for our Server offerings. The Company typically recognized revenue on the license portion of perpetual license arrangements once the customer obtained control of the license, which is generally upon delivery of the license. Revenue from the sale of third-party apps via Atlassian Marketplace is recognized on the date of product delivery given that all of our obligations have been met at that time and on a net basis the Company functions as the agent in the relationship. Revenue from technical account management is recognized over the time period that the customer has access to the service. Revenue from consulting and training is recognized over time as the services are performed. Deferred Contract Acquisition Costs Deferred contract acquisition costs are costs incurred to obtain a contract, if such costs are recoverable, and consist primarily of sales commissions and related payroll taxes. Incremental costs of obtaining a contract are earned on new and expansion contracts which are capitalized and amortized over the average period of benefit that the Company has determined to be four years, which is typically greater than the term of the initial customer contract and reflects the average period of benefit, including anticipated renewals. The Company does not pay sales commissions upon contract renewal. Amortization is commensurate with the pattern of revenue recognition, or when the transfer of control of the related goods or services occurs, over an estimated period of benefit of four years. Therefore, a portion of commissions related to our data center offering is expensed when the control of the license is transferred to the customer, and all other commissions are amortized on a straight-line basis over the four-year period. The Company determines the period of benefit for commissions paid for the acquisition of the initial customer contract by taking into consideration the initial estimated customer life and the technological life of our unified communications platform and related significant features. The Company includes the deferred contract costs in prepaid expense and other current assets and other non-current assets on the condensed consolidated balance sheets and amortization of deferred contract acquisition costs in marketing and sales expense in the condensed consolidated statements of operations. Cash, Cash Equivalents and Restricted Cash Cash and cash equivalents consist of highly liquid investments with an original maturity of three months or less at the date of purchase. Cash equivalents also include amounts due from third-party credit card processors as they are both short-term and highly liquid in nature and are typically converted to cash within three days of the sales transaction. Cash and cash equivalents are stated at fair value. As of December 31, 2022 and June 30, 2022 the Company had restricted cash of $1.4 million, primarily used for the benefit of employees through a deferred compensation plan, which was not available for use in its operations. Restricted cash is included in other non-current assets in the condensed consolidated balance sheets. Accounts Receivable, net The Company records trade accounts receivable at the invoice value, and such receivables are non-interest bearing. The Company considers receivables past due based on the contractual payment terms. The Company makes estimates of expected credit and collectability trends for the allowance for credit losses based on an assessment of various factors, including historical credit loss experience adjusted for forward-looking factors specific to the debtors and the economic environment that may affect our ability to collect from customers. The allowance for credit losses and write-offs were not material for each of the periods as of December 31, 2022 and June 30, 2022. Fair Value Measurements Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy prioritizes the quality and reliability of the information used to determine fair values. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories of inputs: • Level 1 - Quoted (unadjusted) market prices in active markets for identical assets or liabilities; • Level 2 - Observable inputs (other than Level 1 prices) such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; • Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or examination. Marketable Securities The Company classifies all marketable debt securities that have original stated maturities of greater than three months as marketable securities on our condensed consolidated balance sheets. The Company determines the appropriate classification of its investments in marketable debt securities at the time of purchase and reevaluates such designation at each balance sheet date. The Company has classified and accounted for its marketable debt securities as available-for-sale (“AFS”). After consideration of its risk versus reward objectives, as well as its liquidity requirements, the Company may sell these debt securities prior to their stated maturities. The Company considers all of our marketable securities as funds available for use in current operations, including those with maturity dates beyond one year, and therefore classifies these securities as current assets on the condensed consolidated balance sheets. The Company evaluates AFS securities with unrealized loss positions for credit loss by assessing whether the decline in fair value below the amortized cost basis has resulted from a credit loss or other factors, whether the Company expects to recover the entire amortized cost basis of the security, our intent to sell and whether it is more likely than not that the Company will be required to sell the securities before the recovery of their amortized cost basis. The Company carries these securities at fair value, and reports the unrealized gains and losses, net of taxes, as a component of accumulated other comprehensive income except for the changes in allowance for expected credit losses, which are recorded in other income (expense), net. Realized gains and losses are determined based on the specific identification method and are reported in other income (expense), net on the condensed consolidated statements of operations. Strategic Investments The Company holds strategic investments in privately held debt and equity securities, as well as publicly held equity securities in which the Company does not have a controlling interest. Investments in privately held debt securities are classified as AFS securities. Investments in publicly held equity securities are recorded at fair value with changes in the fair value of the investments recorded in other income (expense), net in the condensed consolidated statements of operations. Investments in privately held equity securities without readily determinable fair values in which the Company does not own a controlling interest or have significant influence over are measured in accordance with the measurement alternative. In applying the measurement alternative, the carrying value of the investment is measured at cost, less impairment, if any, plus or minus changes resulting from observable price changes from orderly transactions for the identical or a similar investment of the same issuer in the period of occurrence. Changes to the carrying value of these investments are recorded through other income (expense), net on the condensed consolidated statements of operations. In determining adjustments to the carrying value of its strategic invest ments in privately held companies, the Company uses the most recent data available to the Company. Valuations of privately held securities are inherently complex and the determination of whether an orderly transaction is for an identical or similar investment requires judgment. In its evaluation, the Company considers factors such as differences in the rights and preferences of the investments and the extent to which those differences would affect the fair values of those investments. The Company’s impairment analysis encompasses an assessment of both qualitative and quantitative factors including the investee’s financial metrics, market acceptance of the investee’s product or technology, general market conditions and liquidity considerations. Equity Method Investments Privately held equity securities in which the Company does not have a controlling financial interest but does exercise significant influence over the investment are accounted for under the equity method. The Company records a proportionate share of the investment’s earnings or losses, and impairment, if any, as a component of other income (expense), net in the condensed consolidated statements of operations. These investments are included in strategic investments in the condensed consolidated balance sheets. For entities that meet the definition of a variable interest entity (“VIE”), the Company consolidates those entities when the Company is the primary beneficiary of the entity. The Company is determined to be the primary beneficiary when it possesses both the unilateral power to direct activities that most significantly impact the economic performance of the VIE and the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE. The Company continually evaluates whether it qualifies as the primary beneficiary and reconsiders its determination of whether an entity is a VIE upon reconsideration events. As of December 31, 2022, the Company has one investment in an unconsolidated VIE for which it exercises significant influence over their operations and accordingly accounts for it as an equity method investment. Exchangeable Senior Notes In 2018, the Company, through its subsidiary Atlassian US, Inc., issued exchangeable senior notes due May 1, 2023 (the “Notes”), which were classified as financial liabilities at amortized cost and measured using the effective interest rate (“EIR”) method. Amortized cost was calculated by taking into account any discount and issuance cost that were an integral part of the EIR. The EIR amortization was includ ed as interest expense in the condensed consolidated statements of operations. In connection with the issuance of the Notes, the Company entered into privately negotiated capped call transactions (the “Capped Calls”) with certain financial institutions. The capped call transactions were scheduled to expire in May 2023 and were required to be settled in cash. As of June 30, 2022 the Notes and Capped Calls had been fully settled and are no longer outstanding. Refer to Note 12, “ Debt ” for further details of the transaction. Derivative Financial Instruments The Company enters into foreign exchange forward contracts with the objective to mitigate certain currency risks associated with cost of revenues and operating expenses denominated in foreign currencies. These foreign exchange forward contracts are designated as cash flow hedges. The Company also enters into foreign exchange forward contracts to hedge a portion of certain foreign currency denominated as monetary asse ts and liabilities to reduce the risk that such foreign currency will be adversely affected by changes in exchange rates. The Company uses interest rate swaps to hedge the variability of cash flows in the interest payments associated with its variable-rate debt due to changes in the London inter-bank offered rate (“LIBOR”) based floating interest rate. The interest rate swaps are designated as cash flow hedges and involve interest obligations for U.S. dollar-denominated amounts. T he Company does not enter into derivative instrument transactions for trading or speculative purposes. Hedging derivative instruments are recognized as either assets or liabilities and are measured at fair value. For derivative instruments designated as cash flow hedges, the gains (losses) on the derivatives are initially reported as a component of other comprehensive income and is subsequently recognized in earnings when the hedged exposure is recognized in earnings. For derivative instruments that are not designated as hedges, gains (losses) from changes in fair values are primarily recognized in other income (expense), net. The Company enters into master netting agreements with financial institutions to execute its hedging program. The master netting agreements are with select financial institutions to reduce the Company’s credit risk, as well as to reduce its concentration of risk with any single counterparty. The Company had other derivatives, such as embedded exchange feature of the Notes and Capped Calls. Please see Note 12, “ Debt ” for details. The Notes and Capped Calls were measured at fair value at each reporting date, and gains (losses) from changes in fair values were recognized in other income (expense), net in the consolidated statements of operations. The Company used the Black-Scholes option pricing models to estimate the fair value of the exchange feature of the Notes. Certain inputs used in the model such as stock price volatility requires judgment. The fair value of the Capped Calls was obtained from counterparty banks. Property and Equipment Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method to allocate the cost over the estimated useful lives. The estimated useful lives for each asset class are as follows: Equipment 3 years Computer hardware and computer-related software 3 years Furniture and fittings 5 years Leasehold improvements Shorter of the remaining lease term or 7 years Leases The Company determines if an arrangement is or contains a lease at inception. Operating lease right-of-use assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Operating lease liabilities are recognized at the present value of the future lease payments at the lease commencement date. The interest rate used to determine the present value of the future lease payments is the Company’s incremental borrowing rate, whenever the interest rate implicit in the lease agreement is not readily determinable. The Company’s incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments and in economic environments where the leased asset is located. The term of the lease includes the initial period of use of the leased asset plus any options to extend or terminate the lease when it is reasonably certain that the option will be exercised. The Company reassesses the lease term if and when a significant event or change in circumstances occurs. The carrying value of operating right-of-use assets includes the amount of lease liabilities recognized, initial direct cost incurred, and any prepaid lease payments less lease incentives. Lease expense for minimum operating lease payments is recognized on a straight-line basis over the lease term. This straight-line lease expense represents a single lease cost which is comprised of both the interest accretion component related to the lease liability and amortization of the right-of-use assets. The Company’s lease agreements generally contain lease and non-lease components. Lease payments under these lease arrangements are primarily fixed. Non-lease components primarily include payments for maintenance and utilities and are expensed as incurred. The Company applies the short-term lease recognition exemption for short-term leases, which are leases with a lease term of 12 months or less. Payments associated with short-term leases are recognized on a straight-line basis over the lease term. The Company did not have any finance lease arrangements as of December 31, 2022 and June 30, 2022. Assets Held for Sale The Company classifies assets as held for sale when all of the following are met: (i) management has committed to a plan to sell the assets; (ii) the assets are available for immediate sale in their present condition; (iii) an active program to locate a buyer has been initiated; (iv) it is probable that a sale will occur within one year; (v) the assets are being actively marketed for sale at a price that is reasonable in relation to their current fair value; and (vi) it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn. If all held for sale criteria are met, the assets are reclassified and presented separately in the condensed consolidated balance sheets as assets held for sale at the lower of the carrying value or the fair value, less cost to sell, and no longer depreciated or amortized. The Company completed a sale of assets that had previously been classified as held for sale in July 2022, please refer to Note 10, “Assets Held for Sale” , to our condensed consolidated financial statements for details. Business Combinations The Company allocates the purchase price of acquired companies to the tangible and intangible assets acquired and liabilities assumed, based on their estimated fair values. The excess of the purchase price over the fair values of these identifiable assets and liabilities is recorded as goodwill. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred. The Company uses its best estimates and assumptions to assign fair value to the tangible and intangible assets acquired and liabilities assumed at the acquisition date. Assumptions used to estimate the fair value of the intangible assets include, but are not limited to, revenue growth rates, technology migration curves, customer attrition rates and discount rates. These estimates are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, which may not be later than one year from the acquisition date, the Company may record adjustments to the fair value of these tangible and intangible assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the condensed consolidated statements of operations. Intangible Assets The Company acquires intangible assets separately or in connection with business combinations. Intangible assets are measured at cost initially. Intangible assets with finite lives are amortized over their estimated useful life using the straight-line method. The amortization expense on intangible assets is recognized in the condensed consolidated statements of operations in the expense category consistent with the function of the intangible asset. The estimated useful lives for each intangible asset class are as follows: Patents, trademarks and other rights 5 - 12 years Customer relationships 3 - 10 years Acquired developed technology 4 - 6 years Impairment of Long-Lived Assets The Company evaluates long-lived assets, including purchased intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. Recoverability is measured by comparing the carrying amount to the future undiscounted cash flows the Company expects the asset to generate. Any excess of the carrying value of the asset above its fair value is recognized as an impairment loss. Goodwill Goodwill is the excess of the aggregate of the consideration transferred over the identifiable assets acquired and liabilities assumed. Goodwill is tested for impairment at least annually during the fourth quarter of the Company’s fiscal year and more often if and when circumstances indicate that the carrying value may be impaired. The Company’s reporting unit is at the operating segment level. The Company performs its goodwill impairment test at the level of its operating segment, as there are no levels below the operating segment level for which discrete financial information is prepared and regularly reviewed by the Company’s CODMs. A qualitative assessment is performed to determine whether it is more likely than not that the fair value of its operating segment is less than it’s carrying amount. If the operating segment does not pass the qualitative assessment, the carrying amount of the operating segment, including goodwill, is compared to fair value and goodwill is considered impaired if the carrying value exceeds its fair value. Any excess is recognized as an impairment loss in current period earnings. Stock-based Compensation The Company recognizes compensation expense related to all stock-based awards, including restricted stock units (“RSU”), restricted stock awards and stock options issued to our employees in exchange for their service, based on the estimated fair value of the awards on the grant date. The fair value of each RSU or restricted stock award is based on the fair value of the Company’s common stock on the date of grant. The Company estimated the fair value of stock option awards using the Black-Scholes option pricing model. The Company recognizes costs related to stock-based awards, net of estimated forfeitures, over the awards’ requisite service period on a straight-line basis. The Company estimates forfeitures based on historical experience. The respective expenses are recognized as employee benefits and classified in our condensed consolidated statements of operations according to the activities that the employees perform. In connection with certain business combinations, the Company also issues replacement awards in exchange for awards held by employees of the acquiree. The Company recognizes the portion of the acquiree award that is attributable to pre-combination service as purchase consideration. The portion of the replacement award attributable to post-combination service is recognized as compensation expense and classified in our condensed consolidated statements of operations according to the activities that the employees perform. Refer to Note 15, “Stockholders Equity” for more information. Defined Contribution Plan The Company offers various d

Conversion from IFRS to GAAP

Conversion from IFRS to GAAP	6 Months Ended
	Dec. 31, 2022
Accounting Changes and Error Corrections [Abstract]
Conversion from IFRS to GAAP	Conversion from IFRS to GAAP As part of the U.S. Domestication, the Company has retrospectively converted its Consolidated Financial Statements from International Financial Reporting Standards (“IFRS”) to GAAP. Refer to Note 1, “Description of Business,” for additional details. The significant differences between IFRS and GAAP as they relate to these financial statements are as follows: (a) Stock-based Compensation Under IFRS, prior to the adoption of GAAP, the Company adhered to the accelerated method of expense recognition for stock-based compensation subject to graded vesting. The application of this accounting method results in more of the grant’s stock-based compensation being recognized in the earlier years of the grant. Under GAAP, the Company accounts for stock-based compensation using the straight-line expense method, recognizing the expense ratably over the service period, which is generally four years. This change in the timing of the expense recognition is the primary driver for the GAAP transition differences. The resulting decrease in stock-based compensation expense from the transition from IFRS to GAAP was $91.2 million and $109.3 million for the three and six months ended December 31, 2021, respectively. (b) Leases Under IFRS, prior to the adoption of GAAP, the Company, as lessee, applied the single lease model that is similar to the accounting for a finance lease under GAAP. The expense recognition presented a higher portion of the total expense earlier in the term as a combination of straight-line depreciation of the right-of-use asset and the EIR method applied to the lease liability results in a decreasing rate of interest expense recognition throughout the lease term. Under GAAP, there is dual classification lease accounting model for lessees: finance leases and operating leases. The Company, as lessee, classified all its leases as operating leases and recognizes a single lease expense, including both a right-of-use asset depreciation component and a interest expense component, on a straight-line basis throughout the lease term. This resulted in lease expense being reclassified from interest expense into operating expense under GAAP which decreased interest expense by $1.9 million and $3.6 million for the three and six months ended December 31, 2021, respectively. Additionally due to the change in the expense recognition method, the total resulting decrease in lease related expense from the transition from IFRS to GAAP was $0.6 million and $1.1 million for the three and six months ended December 31, 2021, respectively. (c) Strategic Investments The Company invests in equity securities of public and private companies in which the Company does not have a controlling interest or significant influence. Under IFRS, the movement in the valuation of these investments had been recorded in other comprehensive income. Under GAAP, the Company records any impairment of these equity investments, as well as any changes in value resulting from observable price changes as a result of orderly transactions for identical or similar investments of the same issuer, in the condensed consolidated statements of operations. This change in classification is the primary driver of the GAAP transition differences. The resulting increase in other expense, net from the transition from IFRS to GAAP was $22.1 million and $53.1 million for the three and six months ended December 31, 2021, respectively. (d) Exchangeable Senior Notes In 2018, Atlassian US, Inc. issued $1 billion in aggregate principal amount of the Notes. The Notes were senior, unsecured obligations of the Company, and were scheduled to mature on May 1, 2023, unless earlier exchanged, redeemed or repurchased. The Notes were fully redeemed by the Company in fiscal year 2022. The exchange feature of the Notes required bifurcation from the Notes and was accounted for as a derivative liability. The fair value of the Notes’ embedded exchange derivative at the time of issuance was $177.9 million and was recorded as original debt discount for purposes of accounting for the debt component of the Notes. This discount was amortized as interest expense using the EIR method over the term of the Notes. Under IFRS, the Company determined EIR using estimated cash flows, based on the anticipated timing on cash inflows and outflows. Under GAAP, the Company has calculated EIR using contractual cash flows, focusing on the flow of funds as determined by contractual arrangements. The resulting increase in interest expense resulting from the transition from IFRS to GAAP was $16.9 million and $23.0 million for the three and six months ended December 31, 2021, respectively. (e) Income Taxes Prior to the adoption of GAAP, the Company accounted for income taxes pursuant to International Accounting Standard 12 Income Taxes (“IAS 12”), International Financial Reporting Interpretations Committee 23 Uncertainty over Income Tax Treatments (“IFRIC 23”) and International Accounting Standard 34 Interim Reporting ( “IAS 34”). Upon the adoption of GAAP, the Company now accounts for income taxes pursuant to Accounting Standards Codification 740 Income Taxes (“ASC 740”) as noted below: i. Deferred Tax Deferred tax has been adjusted to remove any backwards tracing components that are permitted under IAS 12 and prohibited under ASC 740. Specifically, backwards tracing is prohibited with regard to adjustments to the beginning of the year balance of a valuation allowance because of a change in judgement about the realizability of related deferred tax assets in future years. Deferred tax liabilities and assets for investments in subsidiaries, partnerships, corporate ventures, and other entities have been assessed based on the criteria in ASC 740 rather than IAS 12. Where applicable, the Company has adopted the exception criteria in establishing whether a deferred tax asset or liability is required to be recognized. The Company acknowledges that a deferred tax asset or liability will be recognized for any investments that are not subject to the exception criteria. Under IFRS, when assessing the recognition of deferred taxes on outside basis differences between the carrying amount of an investment for financial reporting purposes and the underlying tax basis in that investment, the Company had adopted the exceptions in IAS 12 such that no deferred tax assets or liabilities had been recorded on outside basis differences that exist for any controlled subsidiaries. Under GAAP, the Company is required to recognize deferred taxes attributable to outside basis interests in equity accounted investments in addition to fiscally transparent entities such as partnerships and trusts. On that basis, the Company has recorded deferred taxes for the U.S. group’s interest in foreign and domestic fiscally transparent entities, and it is expected to recognize deferred taxes in respect of any equity accounted associate investments that it does not control. ii. Valuation Allowance The realizability of deferred tax assets was considered under GAAP and the determination to maintain a full valuation allowance in the United States and Australia was made. This is a substantially similar result under IFRS. For footnote presentation purposes, all deferred tax assets, liabilities, and valuation allowances are now reported on gross basis rather than a net basis. iii. Uncertain Tax Positions The Company recognizes and measures any uncertain tax positions in accordance with ASC 740 rather than IFRIC 23. Accordingly, the Company recognizes, and measures uncertain tax positions based on a two-step process outlined in the Income Tax section of the Critical Accounting Policies. iv. Stock-Based Compensation Under IFRS, the measurement of the stock-based compensation deferred tax asset is based on an estimate of the future tax deduction based on the current stock price at each reporting period. When the expected tax benefits from equity awards exceed the recorded cumulative recognized expense multiplied by the tax rate, the tax benefit up to the amount of the tax effect of the cumulative book compensation expense is recorded in the condensed consolidated statement of operations; the excess is recorded in equity. When the expected tax benefit is less than the tax effect of the cumulative amount of recognized expense, the entire tax benefit is recorded in the condensed consolidated statement of operations. Under GAAP, the Company measures the stock-based compensation deferred tax asset based on the amount of compensation cost recognized for financial statement purposes. Changes in stock price do not result in a remeasurement of the related deferred tax asset. Upon settlement or expiration, excess tax benefits and tax deficiencies are recognized within the provisions for income taxes. v. Other Pre-tax Changes The tax effects resulting from other accounting changes to pre-tax income, including leases, strategic investments, and notes, are included in the tax provision under GAAP. The reconciliation between IFRS net loss and GAAP net loss for the three and six months ended December 31, 2021 in the Company’s condensed consolidated statements of operations is as follows (in thousands): Three months ended Six months ended Note December 31, 2021 Net loss - IFRS $ (77,472) $ (477,574) Cost of revenues (a), (b) 4,970 6,732 Operating expenses (a), (b) 84,790 99,859 Other expense, net (b), (c) (22,024) (52,895) Interest income (b) (3) (6) Interest expense (b), (d) (14,944) (19,351) Provision for income taxes (e) 2,355 9,703 Net loss - GAAP $ (22,328) $ (433,532) Net losses per share were as follows: Three Months Ended December 31, 2021 Six Months Ended December 31, 2021 IFRS GAAP IFRS GAAP Net loss per share attributable to ordinary shareholders: Basic and diluted $ (0.31) $ (0.09) $ (1.89) $ (1.72) Conversion adjustments impacting the Company’s condensed consolidated balance sheet as of June 30, 2022, were as follows (in thousands): Note IFRS Adjustments GAAP Assets: Prepaid expenses and other current assets (b) $ 72,303 $ (2,301) $ 70,002 Property and equipment, net (b) 98,554 2,108 100,662 Operating lease right-of-use assets (b) 267,328 9,948 277,276 Goodwill (a) 732,666 (9,828) 722,838 Deferred tax assets (e) 42,760 (32,425) 10,335 Other non-current assets (b) 60,740 (1,878) 58,862 Total conversion adjustments $ (34,376) Liabilities and Stockholders' Equity: Deferred tax liabilities (e) $ 26,457 $ (26,145) $ 312 Common stock and Additional paid in capital (a), (e) 2,710,349 (527,811) 2,182,538 Accumulated other comprehensive income (b), (c), (e) 53,829 (39,965) 13,864 Accumulated deficit (a), (b), (c), (e) (2,428,575) 559,545 (1,869,030) Total conversion adjustments $ (34,376)

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2022, by the level within the fair value hierarchy (in thousands): Level 1 Level 2 Total Assets measured at fair value Cash and cash equivalents: Money market funds $ 426,413 $ — $ 426,413 Marketable securities: U.S. treasury securities — 26,069 26,069 Certificates of deposit and time deposits — 10,000 10,000 Derivative financial instruments — 70,514 70,514 Strategic investments: Publicly traded equity securities 19,325 — 19,325 Total assets measured at fair value $ 445,738 $ 106,583 $ 552,321 Liabilities measured at fair value Derivative financial instruments $ — $ 9,537 $ 9,537 Total liabilities measured at fair value $ — $ 9,537 $ 9,537 The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2022, by level within the fair value hierarchy (in thousands): Level 1 Level 2 Total Assets measured at fair value Cash and cash equivalents: Money market funds $ 555,247 $ — $ 555,247 Marketable securities: U.S. treasury securities — 70,294 70,294 Certificates of deposit and time deposits — 3,000 3,000 Derivative financial instruments — 44,052 44,052 Strategic investments: Publicly traded equity securities 30,801 — 30,801 Total assets measured at fair value $ 586,048 $ 117,346 $ 703,394 Liabilities measured at fair value Derivative financial instruments $ — $ 24,100 $ 24,100 Total liabilities measured at fair value $ — $ 24,100 $ 24,100 Due to the short-term nature of accounts receivables, net, contract assets, accounts payable, and accrued expenses and other current liabilities, their carrying amount is assumed to approximate their fair value. Determination of Fair Value The Company uses quoted prices in active markets for identical assets to determine the fair value of the Company’s Level 1 investments. The fair value of the Company’s Level 2 investments is determined based on quoted market prices or alternative market observable inputs. Strategic Investments Measured and Recorded at Fair Value on a Non-Recurring Basis The Company’s investments in privately held companies are not included in the tables above and are discussed in Note 5, “Investments.” The carrying value of the Company’s privately held equity securities are adjusted on a non-recurring basis upon observable price changes in orderly transactions for identical or similar investments of the same issuer, or impairment (referred to as the measurement alternative). Privately held equity securities that have been remeasured during the period based on observable price changes in orderly transactions are classified within Level 2 or Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods which may include a combination of the observable transaction price at the transaction date and other unobservable inputs including volatility, rights and preferences of the investments, and obligations of the securities the Company holds. The fair value of privately held equity securities that have been remeasured due to impairment are classified within Level 3. The Company’s privately held debt and equity securities amounted to $130.1 million and $128.3 million as of December 31, 2022 and June 30, 2022, respectively.

Investments

Investments	6 Months Ended
	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Investments	Investments Marketable Securities The Company’s investments of marketable securities as of December 31, 2022, consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. treasury securities $ 26,250 $ — $ (181) $ 26,069 Certificates of deposit and time deposits 10,000 — — 10,000 Total marketable securities $ 36,250 $ — $ (181) $ 36,069 The Company’s investments of marketable securities as of June 30, 2022, consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. treasury securities $ 70,947 $ — $ (653) $ 70,294 Certificates of deposit and time deposits 3,000 — — 3,000 Total marketable securities $ 73,947 $ — $ (653) $ 73,294 The table below summarizes the Company’s marketable securities by remaining contractual maturity based on their effective maturity dates (in thousands): December 31, 2022 June 30, 2022 Due in one year or less $ 36,069 $ 73,294 The Company regularly reviews the changes to the rating of its marketable securities by rating agencies and monitors the surrounding economic conditions to assess the risk of expected credit losses. As of December 31, 2022 and June 30, 2022, the unrealized losses and the related risk of expected credit losses were not material. Strategic Investments Carrying value of privately held debt securities The Company’s investments of privately held debt securities as of December 31, 2022, consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Fair Value Privately held debt securities $ 5,462 $ — $ (3,503) $ 1,959 The Company’s investments of privately held debt securities as of June 30, 2022, consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Fair Value Privately held debt securities $ 5,486 $ — $ (4,218) $ 1,268 Carrying value of publicly traded and privately held equity securities The carrying value is measured as the total initial cost plus the cumulative net gain (loss). Publicly traded equity securities are recorded at fair value and privately held equity securities are measured using the measurement alternative. The carrying values for publicly traded and privately held equity securities as of December 31, 2022 are summarized below (in thousands): Publicly traded equity securities Privately held Total Initial total cost $ 10,270 $ 128,800 $ 139,070 Cumulative net gain (loss) 9,055 (687) 8,368 Carrying Value $ 19,325 $ 128,113 $ 147,438 Privately held equity securities cumulative net gain (loss) is comprised of upward adjustments of $5.5 million and downward adjustments and impairment of $6.2 million as of December 31, 2022. The carrying values for publicly traded and privately held equity securities as of June 30, 2022 are summarized below (in thousands): Publicly traded equity securities Privately held Total Initial total cost $ 10,270 $ 120,300 $ 130,570 Cumulative net gain 20,531 6,695 27,226 Carrying Value $ 30,801 $ 126,995 $ 157,796 Privately held equity securities cumulative net gain is comprised of upward adjustments of $6.7 million as of June 30, 2022. Gains and Losses on Strategic Investments The components of gains and losses on strategic investments were as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Unrealized losses recognized on publicly traded equity securities $ (1,669) $ (22,135) $ (11,477) $ (57,945) Unrealized gains recognized on privately held equity securities 260 — 260 4,388 Unrealized losses recognized on privately held equity securities including impairment (5,927) — (7,642) — Unrealized gains (losses), net $ (7,336) $ (22,135) $ (18,859) $ (53,557) Realized losses on debt securities (212) — (212) — Losses on strategic investments, net $ (7,548) $ (22,135) $ (19,071) $ (53,557) Unrealized gains and losses recognized during the reporting period on privately held equity securities still held at the reporting date $ (5,667) $ — $ (7,382) $ 4,388 Unrealized gains recognized on privately held equity securities includes upward adjustments from equity securities accounted for under the measurement alternative while unrealized losses recognized on privately held equity securities includes downward adjustments and impairment. Equity Method Investment On July 20, 2022, the Company completed a non-cash sale of its controlling interest of Vertical First Trust (“VFT”) to a third-party buyer. Please refer to Note 10, “ Assets held for sale ,” for additional details. The Company retained a minority equity interest of 13% in the form of ordinary units and has significant influence in VFT. The Company’s interest in VFT is accounted for using the equity method in the condensed consolidated financial statements. The Company used a discounted cash flow model to calculate the fair value of its retained equity interest. The fair value of the retained interest was $88.9 million, and is classified as a Level 3 investment in the fair value hierarchy. The inputs to the valuation included observable inputs, including capitalization rate, discount rate, and other management inputs, including the underlying building practical completion date. The maximum exposure to loss related to the Company’s investment in VFT equals the Company’s capital investment. The following table sets forth the carrying amounts of the equity method investment and the movements during the six months ended December 31, 2022 (in thousands): Equity Method Investment Balance as of July 20, 2022 $ 88,853 Effect of change in exchange rates (1,069) Balance as of December 31, 2022 $ 87,784 The carrying amount of the Company’s investment in VFT was reported within strategic investments in the condensed consolidated balance sheets. The Company’s share in the profits and losses of VFT was not material during the three and six months ended December 31, 2022.

Derivative Contracts

Derivative Contracts	6 Months Ended
	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Contracts	Derivative Contracts The Company has derivative instruments that are used for hedging activities as discussed below. The following table sets forth the notional amounts of the Company’s hedging derivative instruments as of December 31, 2022 (in thousands, except for average interest rate): Notional Amounts of Derivative Instruments Notional Amount by Term to Maturity Classification by Notional Amount Under 12 months Over 12 months Total Cash Flow Hedge Non Hedge Total Forward contracts $ 658,857 $ 35,067 $ 693,924 $ 447,419 $ 246,505 $ 693,924 Interest rate swaps: Notional amount $ — $ 650,000 $ 650,000 $ 650,000 $ — $ 650,000 Average interest rate 0.81 % 0.81 % 0.81 % 0.81 % The following table sets forth the notional amounts of the Company’s hedging derivative instruments as of June 30, 2022 (in thousands, except for average interest rate): Notional Amounts of Derivative Instruments Notional Amount by Term to Maturity Classification by Notional Amount Under 12 months Over 12 months Total Cash Flow Hedge Non Hedge Total Forward contracts $ 612,523 $ 37,015 $ 649,538 $ 401,534 $ 248,004 $ 649,538 Interest rate swaps: Notional amount $ — $ 650,000 $ 650,000 $ 650,000 $ — $ 650,000 Average interest rate 0.81 % 0.81 % 0.81 % 0.81 % The fair value of the Company’s derivative instruments were as follows (in thousands): Balance Sheet Location December 31, 2022 June 30, 2022 Derivative assets Derivatives designated as hedging instruments: Foreign exchange forward contracts Prepaid expenses and other current assets $ 6,524 $ — Foreign exchange forward contracts Other non-current assets 1,464 — Interest rate swaps Prepaid expenses and other current assets 25,662 13,296 Interest rate swaps Other non-current assets 34,375 30,367 Derivatives not designated as hedging instruments: Foreign exchange forward contracts Prepaid expenses and other current assets 2,489 389 Total derivative assets $ 70,514 $ 44,052 Derivative liabilities Derivatives designated as hedging instruments: Foreign exchange forward contracts Accrued expenses and other current liabilities $ 9,067 $ 18,208 Foreign exchange forward contracts Other non-current liabilities — 812 Derivatives not designated as hedging instruments: Foreign exchange forward contracts Accrued expenses and other current liabilities 470 5,080 Total derivative liabilities $ 9,537 $ 24,100 The pre-tax effects of derivatives designated as cash flow hedging instruments on the condensed consolidated financial statements were as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Beginning balance of accumulated gains (losses) in accumulated other comprehensive loss $ 28,471 $ (15,697) $ 24,502 $ (2,936) Gross unrealized gains (losses) recognized in other comprehensive loss 21,881 9,753 22,167 (4,106) Net (gains) losses reclassified from cash flow hedge in accumulated other comprehensive income into profit or loss: Recognized in cost of revenues 611 166 1,125 (14) Recognized in research and development 8,386 1,695 11,865 2,564 Recognized in marketing and sales 366 83 772 38 Recognized in general and administrative 2,149 227 3,730 (102) Recognized in interest expense (4,638) 1,203 (6,935) 1,986 Ending balance of accumulated gains (losses) in accumulated other comprehensive income (loss) $ 57,226 $ (2,570) $ 57,226 $ (2,570)

Property and Equipment

Property and Equipment	6 Months Ended
	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and Equipment Property and equipment, net consisted of the following (in thousands): December 31, 2022 June 30, 2022 Equipment $ 9,660 $ 9,140 Computer Hardware and Software 27,804 18,324 Furniture and Fittings 24,723 25,157 Leasehold Improvements and Other 128,443 124,758 Property and equipment, gross 190,630 177,379 Less: accumulated depreciation (90,296) (76,717) Property and equipment, net $ 100,334 $ 100,662

Goodwill and Intangible Assets

Goodwill and Intangible Assets	6 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill Goodwill represents the excess of the purchase price in a business combination over the fair value of net tangible and intangible assets acquired. Goodwill amounts are not amortized, but rather are tested for impairment at least annually during the fourth quarter, or when indicators of impairment exist. Goodwill consisted of the following (in thousands): Goodwill Balance as of June 30, 2022 $ 722,838 Effect of change in exchange rates 391 Balance as of December 31, 2022 $ 723,229 Intangible Assets Intangible assets consisted of the following (in thousands): December 31, 2022 June 30, 2022 Weighted-Average Remaining Useful Lives Acquired Developed Technology $ 234,618 $ 234,618 2 Patents, Trademarks, and Other Rights 33,393 33,393 5 Customer Relationships 129,502 129,502 5 Intangible assets, gross 397,513 397,513 Less: accumulated amortization (313,265) (296,673) Intangible assets, net $ 84,248 $ 100,840 Amortization expense for intangible assets were approximately $8.3 million and $8.0 million for the three months ended December 31, 2022 and 2021, respectively, and $16.6 million and $16.0 million for the six months ended December 31, 2022 and 2021, respectively. The following tables presents the estimated future amortization expense related to intangible assets held as of December 31, 2022 (in thousands): Fiscal Years: Remainder of 2023 $ 16,310 2024 26,267 2025 14,908 2026 12,370 2027 7,267 Thereafter 7,126 Total future amortization expense $ 84,248

Leases

Leases	6 Months Ended
	Dec. 31, 2022
Leases [Abstract]
Leases	Leases The Company rents office space and equipment under non-cancelable operating leases with various expiration dates through fiscal year 2034. Certain lease agreements include varying terms, escalation clauses and renewal rights. The Company does not assume renewals in its determination of the lease term unless the renewals are deemed to be reasonably certain at lease commencement. The Company’s lease agreements generally do not contain any material residual value guarantees or material restrictive covenants. The components of lease costs and other information related to leases were as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Operating lease costs $ 13,143 $ 12,824 $ 26,337 $ 24,415 Short-term lease costs 71 110 98 268 Total lease costs $ 13,214 $ 12,934 $ 26,435 $ 24,683 December 31, 2022 June 30, 2022 Weighted average remaining lease term (in years) 8 8 Weighted average discount rate 2.4 % 2.4 % Supplemental cash flow information related to operating leases were as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Cash paid for amounts included in the measurement of operating lease liabilities $ 12,480 $ 11,626 $ 25,662 $ 23,812 Lease liabilities arising from obtaining right-of-use assets and receipt of lease incentive $ — $ 994 $ 11,905 $ 92,743 Future lease payments under non-cancelable operating leases with initial lease terms in excess of one year included in the Company’s lease liabilities as of December 31, 2022 were as follows (in thousands): Fiscal years: Operating Lease Payments Remainder of 2023 $ 27,892 2024 51,351 2025 48,701 2026 41,710 2027 36,755 Thereafter 127,981 Total future operating lease payments 334,390 Less: imputed interest (30,078) Total lease liability balance $ 304,312 The Company entered into an Agreement for Lease (the “AFL”) for its new global headquarters in Sydney, Australia (the “Australian HQ Property”) in March 2022. Following completion of the development of the Australian HQ Property, the AFL requires the Company to enter into a lease agreement for the planned headquarters office space. The lease is expected to commence in fiscal year 2027 and will continue for 15 years, with the Company’s option to extend the term for up to two additional ten-year periods. Future lease payments are approximately $944.6 million as of December 31, 2022, for the initial term of 15 years. Please refer to Note 5, “ Investments, ” and Note 10, “A ssets held for sale ,” for details of the transaction.

Assets Held for Sale

Assets Held for Sale	6 Months Ended
	Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Assets Held for Sale	Assets Held for Sale During the fourth quarter of the fiscal year 2021, the Company committed to a plan to sell its controlling interest of its subsidiary, VFT, which was established for the construction project associated with the Australian HQ Property. In July 2021, the Company entered into a term sheet with a third-party buyer to effect the sale. The term sheet provided a framework for the buyer to invest in and develop the Australian HQ Property. In March 2022, the Company entered into a series of agreements with the buyer, including an AFL. On July 20, 2022, the Company completed a non-cash sale of its controlling interest of VFT to the buyer and recognized a gain of $2.1 million and $45.2 million, respectively, from the sale in other income (expense), net, in the condensed consolidated statements of operations during the three and six months ended December 31, 2022, representing the difference between the fair value of the Company’s retained investment and the derecognized VFT assets and liabilities upon loss of control. Please refer to Note 5, “ Investments ” for additional details. The major assets classified as held for sale as of December 31, 2022 and June 30, 2022 were as follows (in thousands): December 31, 2022 June 30, 2022 Cash and cash equivalents $ — $ 2,701 Property and equipment, net $ — $ 57,482

Accrued Expenses and Other Curr

Accrued Expenses and Other Current Liabilities	6 Months Ended
	Dec. 31, 2022
Other Liabilities Disclosure [Abstract]
Accrued Expenses and Other Current Liabilities	Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consist of the following (in thousands): December 31, 2022 June 30, 2022 Accrued expenses $ 115,827 $ 123,381 Employee benefits 126,012 197,701 Tax liabilities 38,011 26,367 Customer deposits 10,131 9,718 Derivative liabilities 9,537 23,288 Liabilities held for sale — 17,564 Other payables 9,412 8,120 Total accrued expenses and other liabilities $ 308,930 $ 406,139

Debt

Debt	6 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Debt	Debt Exchangeable Senior Notes 2023 Exchangeable Senior Notes In 2018, Atlassian US, Inc., issued $1 billion in aggregate principal amount of the Notes. The Notes were senior, unsecured obligations of the Company, and were scheduled to mature on May 1, 2023, unless earlier exchanged by investors, or redeemed or repurchased by the Company. In connection with the issuance of the Notes, the Company entered into privately negotiated Capped Calls with certain financial institutions. The aggregate cost of the Capped Calls was $87.7 million. The capped call transactions were scheduled to expire in May 2023 and were required to be settled in cash. The exchange feature of the Notes required bifurcation from the Notes and was accounted for as a derivative liability. The capped call transactions were accounted for as derivative assets. The Notes embedded exchange derivative liability and capped call assets were carried on the condensed consolidated balance sheets at their estimated fair values and were adjusted at the end of each reporting period, with unrealized gain or loss reflected in the condensed consolidated statements of operations. The current or non-current classification of the embedded exchange derivative liability and the Capped Calls asset corresponded with the classification of the Notes on the condensed consolidated balance sheets. The classification was evaluated at each balance sheet date. The Notes and Capped Calls were fully settled in fiscal year 2022. There was no balance outstanding related to the Notes as of December 31, 2022 and June 30, 2022. No net gain or loss on exchange derivative and capped call transactions was recognized during the three months ended December 31, 2021, and $424.5 million of net loss on exchange derivative and capped call transactions were recognized during the six months ended December 31, 2021. Credit Facility In October 2020, Atlassian US, Inc. entered into a credit agreement (the “Credit Agreement”) establishing a $1 billion senior unsecured delayed-draw term loan facility (the “Term Loan Facility”) and a $500 million senior unsecured revolving credit facility (the “Revolving Credit Facility,” and together with the Term Loan Facility, the “Credit Facility”). The Company used the net proceeds of the Credit Facility for general corporate purposes, including repayment of the then existing indebtedness. The Credit Facility matures in October 2025 and bears interest, at the Company’s option, at a base rate plus a margin up to 0.50% or LIBOR rate plus a spread of 0.875% to 1.50%, in each case with such margin being determined by the Company’s consolidated leverage ratio. The Revolving Credit Facility may be borrowed, repaid, and re-borrowed until its maturity, and the Company has the option to request an increase of $250 million in certain circumstances. The Company may prepay the Credit Facility at its discretion without penalty. Commencing on October 31, 2023, the Company is obligated to repay the outstanding principal amount of the Term Loan Facility in installments on a quarterly basis in an amount equal to 1.25% of the Term Loan Facility borrowing amount until the maturity of the Term Loan Facility. The Company incurred debt issuance costs of $4.4 million in connection with entering into the Credit Facility. The debt issuance costs were amortized over the terms of the Term Loan Facility and Revolving Credit Facility. As of December 31, 2022, $1.0 billion has been drawn under the Term Loan Facility. The Company is also obligated to pay a ticking fee and a commitment fee on the undrawn amounts of the Term Loan Facility and Revolving Credit Facility, respectively, at an annual rate ranging from 0.075% to 0.20%, determined by the Company’s consolidated leverage ratio. The Credit Facility requires compliance with various financial and non-financial covenants, including affirmative and negative covenants. The financial covenants include a maximum consolidated leverage ratio of 3.5x, which ratio increases to 4.5x during the period of four fiscal quarters immediately following a material acquisition. As of December 31, 2022, the Company was in compliance with all related covenants. On September 30, 2022, prior to the consummation of the U.S. Domestication, Atlassian Corporation Plc entered into Amendment No. 1 to the Credit Agreement (the “First Amendment”). The First Amendment sets forth the requirements for the assumption of the obligations of Atlassian Corporation Plc by Atlassian Corporation under the Credit Agreement and provides that the financial statements required to be delivered under the Credit Agreement, as amended, will be prepared in accordance with GAAP and financial definitions under the Credit Agreement, as amended, will be interpreted in accordance with GAAP.

Commitments

Commitments	6 Months Ended
	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments	Commitments Noncancellable Purchase Obligations The Company has contractual commitments for services with third-parties related to its cloud services platform and other infrastructure services. These commitments are non-cancellable and expire within one Operating Leases Please refer to Note 9, “ Leases ,” for a lease commitment that the Company has entered but the lease has not yet commenced. Legal Proceedings From time to time, the Company is party to litigation and other legal proceedings in the ordinary course of business. While the results of any litigation or other legal proceedings are uncertain, management does not believe the ultimate resolution of any pending legal matters is likely to have a material adverse effect on the Company’s financial position, results of operations or cash flows, except for those matters for which a loss contingency is recorded. The Company accrues for loss contingencies when it is both probable that it will incur the loss and when it can reasonably estimate the amount of the loss or range of loss. For the periods presented, the Company has not recorded any liabilities as a result of the litigation or other legal proceedings in its condensed consolidated financial statements. Indemnification Provisions The Company’s agreements include provisions indemnifying customers against intellectual property and other third-party claims. In addition, the Company has entered into indemnification agreements with its directors, executive officers and certain other officers that will require the Company to, among other things, indemnify these individuals for certain liabilities that may arise as a result of their affiliation with the Company. For the periods presented, the Company has not incurred any costs as a result of such indemnification obligations and has not recorded any liabilities related to such obligations in the condensed consolidated financial statements.

Revenue

Revenue	6 Months Ended
	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Remaining Performance Obligations Transaction price allocated to the remaining performance obligations represents contracted revenue that has not yet been recognized, which includes unearned revenue and unbilled amounts that will be recognized as revenue in future periods. Transaction price allocated to the remaining performance obligations is influenced by several factors, including the timing of renewals, the timing of delivery of software licenses, average contract terms, and foreign currency exchange rates. Unbilled portions of the remaining performance obligations are subject to future economic risks including bankruptcies, regulatory changes and other market factors. As of December 31, 2022, approximately $1.4 billion of revenue is expected to be recognized from transaction price allocated to remaining performance obligations. The Company expects to recognize revenue on approximately 85% of these remaining performance obligations over the next 12 months with the balance recognized thereafter. Disaggregated Revenue The Company’s revenues by geographic region based on end-users who purchased the Company’s products or services are as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Americas United States $ 373,976 $ 304,755 $ 731,724 $ 574,717 Other Americas 55,733 43,501 107,906 82,263 Total Americas $ 429,709 $ 348,256 $ 839,630 $ 656,980 EMEA 343,770 263,695 648,048 498,709 Asia Pacific 99,225 76,575 192,418 146,861 Total revenues $ 872,704 $ 688,526 $ 1,680,096 $ 1,302,550 The Company provides different deployment options for its product offerings. Cloud offerings provide customers the right to use the Company’s software in a cloud-based infrastructure that the Company provides. Data Center offerings are on-premises term license agreements for the Company’s Data Center products, which are software licensed for a specified period, and includes support and maintenance service that is bundled with the license for the term of the license period. Server offerings include the license of software on a perpetual basis to customers for use on the customer’s premises and support and maintenance service of unspecified future updates, upgrades and enhancements and technical product support. Marketplace and services offerings mainly include fees received for sales of third-party apps in the Atlassian Marketplace and services like premier support, technical account management, consulting and training. Premier support consists of subscription-based arrangements for a higher level of support across different deployment options, and revenues from this offering are included in Subscription revenues within the Company’s condensed consolidated statements of operations. Premier support revenues were $4.6 million and $5.8 million for the three months ended December 31, 2022 and 2021, respectively, and $9.3 million and $12.0 million for the six months ended December 31, 2022 and 2021, respectively. The Company’s revenues by deployment options are as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Cloud $ 512,335 $ 364,099 $ 987,378 $ 682,002 Data Center 194,264 139,108 365,492 250,303 Server 106,168 135,519 219,981 275,066 Marketplace and services 59,937 49,800 107,245 95,179 Total revenues $ 872,704 $ 688,526 $ 1,680,096 $ 1,302,550 Deferred Revenue The Company records deferred revenues when cash payments are received or due in advance of the Company’s performance, including amounts which are refundable. The changes in the balances of contract balances are as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Balance, beginning of period $ 1,172,834 $ 911,050 $ 1,182,680 $ 897,595 Additions 973,951 752,954 1,771,497 1,380,433 Revenue (872,704) (688,526) (1,680,096) (1,302,550) Balance, end of period $ 1,274,081 $ 975,478 $ 1,274,081 $ 975,478 The additions in the deferred revenue balance are primarily cash payments received or due in advance of satisfying the Company’s performance obligations. For the three months ended December 31, 2022 and 2021, approximately 36% and 34% of revenue recognized was from the deferred revenue balances at the beginning of each fiscal year, respectively. For the six months ended December 31, 2022 and 2021, approximately 46% and 44% of revenue recognized was from the deferred revenue balances at the beginning of each fiscal year, respectively. Deferred Contract Acquisition Costs The changes in the balances of deferred contract acquisition costs are as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Balance, beginning of period $ 29,729 $ 10,722 $ 27,141 $ 9,011 Additions 11,286 3,911 16,415 6,637 Amortization expense (3,027) (1,430) (5,568) (2,445) Balance, end of period $ 37,988 $ 13,203 $ 37,988 $ 13,203 Deferred contract acquisition costs included in: Prepaid expenses and other current assets $ 12,466 $ 4,756 Other non-current assets 25,522 8,447 Total $ 37,988 $ 13,203 The Company periodically reviews these deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. There were no impairment losses recorded during the periods presented.

Stockholder's Equity

Stockholder's Equity	6 Months Ended
	Dec. 31, 2022
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Common Stock As discussed in Note 1, “Description of Business,” the Company completed the U.S. Domestication after the close of market trading on September 30, 2022. At that time all issued and outstanding ordinary shares of Atlassian Corporation Plc were exchanged on a one-for-one basis for newly issued shares of corresponding common stock of Atlassian Corporation, and all issued and outstanding equity awards of Atlassian Corporation Plc were assumed by Atlassian Corporation and were converted into rights to acquire Atlassian Corporation shares of Class A Common Stock on the same terms. As of December 31, 2022, the Company’s common stock consists of Class A Common Stock and Class B Common Stock, which have a par value of $0.00001. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock in the following circumstances: (1) upon the written consent of the holders of at least 66.66% of the total number of outstanding shares of Class B Common Stock; (2) if the aggregate number of shares of Class B Common Stock then outstanding comprises less than ten percent (10%) of the total number of shares of Class A Common Stock and Class B Common Stock then outstanding; and (3) upon any transfer to a person that is not a permitted transferee described in the Company’s amended and restated certificate of incorporation. Any dividend declared by the Company shall be paid on the Class A Common Stock and the Class B Common Stock pari passu as if they were all stock of the same class. Additionally, upon the liquidation, dissolution, or winding up of the Company, whether voluntary or involuntary, holders of Class A Common Stock and Class B Common Stock will be entitled to receive ratably on a per share basis all assets of the Company available for distribution to its stockholders, unless disparate or different treatment of the shares of each such class is approved by the affirmative vote of the holders of a majority of the outstanding shares of Class A Common Stock and by the affirmative vote of the holders of a majority of the outstanding shares of Class B Common Stock, each voting separately as a class. Each share of Class A Common Stock is entitled to one vote. Each share of Class B Common Stock is entitled to 10 votes. Preferred Stock The Company’s board of directors has the authority to issue up to 10,000,000 shares of preferred stock in one or more series. The Company’s board of directors may designate the rights, preferences, privileges and restrictions of the preferred stock, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, the right to elect directors to and increase or decrease the number of shares of any series. As of December 31, 2022 and June 30, 2022, no shares of preferred stock were outstanding. Stock-based Compensation Upon the completion of the U.S. Domestication, the Company assumed the following plans: the Atlassian Corporation Plc 2015 Share Incentive Plan (the “2015 Plan”); the Atlassian Corporation Plc 2013 U.S. Share Option Plan (the “2013 U.S. Option Plan”); and the 2015 Employee Share Purchase Plan (the “ESPP” and, together with the 2015 Plan and the 2013 U.S. Option Plan, the “Incentive Plans”). The Atlassian UK Employee Share Option Plan was not assumed by the Company as there were no stock option awards outstanding at the time of the U.S. Domestication. In connection with its assumption of the Incentive Plans, the Company amended and restated the 2015 Plan as the Atlassian Corporation Amended and Restated 2015 Share Incentive Plan, the ESPP as the Atlassian Corporation Amended and Restated 2015 Employee Share Purchase Plan and the 2013 U.S. Option Plan as the Atlassian Corporation Amended and Restated 2013 U.S. Share Option Plan, in each case to reflect the assumption and changes in applicable law and to provide that the securities to be issuable in connection with equity awards will be shares of the Company’s Class A Common Stock instead of Atlassian Corporation Plc Class A ordinary shares. In addition, Atlassian Corporation assumed each option to purchase Atlassian Corporation Plc Class A ordinary shares and each restricted share unit award covering Atlassian Corporation Plc Class A ordinary shares that was outstanding under an equity incentive plan and amended such option or restricted share unit award to reflect the assumption by Atlassian Corporation and to provide for the securities issuable in connection with the exercise or settlement of the option or award to be shares of Atlassian Corporation’s Class A Common Stock. At December 31, 2022, the Company had 31,899,903 shares of its common stock available for future issuance under the 2015 Plan, which plan provides for the issuance of incentive and non-statutory share options, share appreciation rights, restricted stock awards, RSUs, unrestricted stock awards, cash-based awards, performance stock awards, performance-based awards to covered employees, and dividend equivalent rights to qualified employees, directors and consultants. The Company currently does not have common stock outstanding or open offering periods under the ESPP. RSU grants generally vest over four years with 25% vesting on the one year anniversary of the date of grant and 1/12 th of the remaining RSUs vesting over the remaining three years, on a quarterly basis. Effective from April 2021, new RSU grants to existing employees vest evenly over four years on a quarterly basis. Performance-based RSUs have non-market performance vesting conditions. Individuals must continue to provide services to the Company i n order to vest. The 2013 U.S. Option Plan allowed for the issuance of options to purchase restricted shares. Effective upon the Company’s IPO, the shares underlying the options converted to Class A ordinary shares, and subsequently, following the U.S. Domestication, converted to Class A Common Stock. Although no future awards will be granted under the Option Plans, they will continue to govern outstanding awards granted thereunder. All stock-based compensation is measured based on the grant date fair value of the awards and recognized in the condensed consolidated statements of operations over the period during which the employee is required to perform services in exchange for the award (generally the four-year vesting period of the award, with the exception of restricted stock). A summary of RSU activity for the six months ended December 31, 2022 was as follows (in thousands except share and per share data): Number of Shares Weighted Average Grant Date Fair Value Aggregate Intrinsic Value Balance as of June 30, 2022 6,023,997 $ 257.62 $ 1,128,897 Granted 6,599,428 $ 237.66 Vested (1,344,975) $ 230.99 $ 260,126 Forfeited or cancelled (420,983) $ 270.12 Balance as of December 31, 2022 10,857,467 $ 248.31 $ 1,397,139 As of December 31, 2022, total compensation cost not yet recognized in the condensed consolidated financial statements related to employee and director RSU awards was $2.0 billion, which is expected to be recognized over a weighted-average period of 2 years. During the six months ended December 31, 2022 and 2021, the Company did not grant shares of restricted stock. As of December 31, 2022 and June 30, 2022, there were 19,929 and 72,484 shares of restricted stock outstanding, respectively. These outstanding shares of restricted stock are subject to forfeiture or repurchase at the original exercise price during the repurchase period following employee termination, as applicable. The total aggregate intrinsic value of outstanding shares of restricted stock were $2.6 million and $13.6 million as of December 31, 2022 and June 30, 2022, respectively. Of the total stock-based compensation expense, costs recognized for awards granted to non-employees were immaterial for all periods presented.

Net Loss Per Share

Net Loss Per Share	6 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share The Company computes net loss per share of Class A and Class B Common Stock using the two-class method. As the liquidation and dividend rights for both Class A and Class B Common Stock are identical, the net loss is allocated on a proportionate basis to the weighted-average number of shares of common stock outstanding for the period. Basic net loss per share attributable to Class A and Class B stockholders is computed by dividing the net loss by the weighted-average number of Class A and Class B Common Stock outstanding during the period. For the calculation of diluted net loss per share, net loss for basic EPS is adjusted by the effect of dilutive securities, including awards under the Company’s equity compensation plans. The dilutive potential shares of common stock are computed using the treasury stock method or the as-if converted method, as applicable. Since the Company is in a loss position for all periods reported, basic and diluted net loss per share are the same as diluted net loss per share for all periods as the inclusion of potential dilutive shares would have been anti-dilutive. The following tables present the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Class A Class B Class A Class B Class A Class B Class A Class B Numerator: Net Loss $ (119,094) $ (85,937) $ (12,413) $ (9,915) $ (126,357) $ (92,415) $ (239,710) $ (193,822) Denominator: Weighted-average shares outstanding, basic and diluted 148,627 107,247 140,629 112,331 147,582 107,938 139,632 112,901 Net loss per share, basic and diluted $ (0.80) $ (0.80) $ (0.09) $ (0.09) $ (0.86) $ (0.86) $ (1.72) $ (1.72) The potential weighted average dilutive securities that were not included in the dilutive earnings per share calculation because the effect would be anti-dilutive are as follows (shares in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Class A Common Stock options — 1 1 1 Class A restricted stock units 9,167 3,036 6,976 3,283 Class A restricted stock awards 17 94 24 113 Total 9,184 3,131 7,001 3,397

Income Taxes

Income Taxes	6 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company computes its provision for income taxes by applying the estimated annual effective tax rate to year-to-date ordinary income and adjusts the provision for discrete tax items recorded in the period. In each quarter, the Company updates the estimated annual effective tax rate and make a year-to-date adjustment to the provision. The estimated annual effective tax rate is subject to volatility due to several factors, including changes in the Company’s domestic and foreign earnings, current cash taxes in jurisdictions with full valuation allowances, material discrete tax items, or a combination of these factors as a result of certain transactions or events. The Company reported an income tax provision of $100.5 million on pretax loss of $104.5 million and an income tax provision of $108.5 million on pretax loss of $110.2 million for the three and six months ended December 31, 2022, respectively, as compared to an income tax provision of $2.1 million on pretax loss of $20.2 million and an income tax provision of $2.7 million on pretax loss of $430.8 million for the three and six months ended December 31, 2021, respectively. The income tax provision for the three and six months ended December 31, 2022 reflects an increase in tax expense primarily attributable to the recognition of a reserve for uncertain tax positions, overall growth in foreign jurisdictions associated with an increase in profit and non-deductible stock-based compensation. The Company’s effective tax rate substantially differed from the U.S. statutory income tax rate of 21.0% primarily due to the recognition of a reserve for uncertain tax positions, different tax rates, non-deductible stock-based compensation in foreign jurisdictions, in addition to full valuation allowances in the U.S. and Australia. Since fiscal year 2020, the Company has been in unilateral Advanced Pricing Agreement (“APA”) negotiations with the Australian Taxation Office (“ATO”) relating to the Company’s transfer pricing arrangements between Australia and the U.S. During the three months ended December 31, 2022, the ATO and the Company discussed, for the first time, a framework to resolve the Company’s transfer pricing arrangements for the APA period (tax years ended June 30, 2019 to June 30, 2025). Given the stage of discussions with ATO during the three months ended December 31, 2022, the Company recorded a reserve for uncertain tax positions of $83.0 million based upon applying the recognition and measurement thresholds of ASC 740. Although the Company’s recorded tax reserves are the best estimate of its liabilities, differences may occur in the future, depending on resolution of the APA negotiations. The negotiations are expected to be finalized within the next 12 months. The gross unrecognized tax benefit of $83.0 million, if realized, would affect the Company’s effective tax rate. The Company does not have any other material audits or negotiations that are currently in progress. The Tax Cuts and Jobs Act (the “TCJA”), enacted on December 22, 2017, eliminates the option to deduct research and development expenditures, instead requiring taxpayers to capitalize and amortize such expenditures over five or fifteen years beginning in fiscal year 2023. If not deferred, modified or repealed, this provision may materially increase future cash taxes. The Inflation Reduction Act of 2022 (the “IRA”) was enacted on August 16, 2022 and includes various corporate tax provisions, including a new alternative corporate minimum tax on applicable corporations with adjusted financial statement income exceeding $1 billion, on average, over the last three years. As of December 31, 2022, the newly enacted tax provisions are not applicable to the Company. The Company regularly assesses the need for a valuation allowance against its deferred tax assets. The Company’s assessment is based on all positive and negative evidence related to the realizability of such deferred tax assets. Based on available objective evidence as of December 31, 2022, the Company will continue to maintain a full valuation allowance on its U.S. federal, U.S. state, and Australian deferred tax assets as it is more likely than not that these deferred tax assets will not be realized. The Company intends to maintain the full valuation allowance until sufficient positive evidence exists to support the reversal of, or decrease in, the valuation allowance.

Subsequent Events

Subsequent Events	6 Months Ended
	Dec. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventsIn January 2023, the Board of Directors authorized a program to repurchase up to $1.0 billion of the Company’s outstanding Class A Common Stock (the “Share Repurchase Program”). The Share Repurchase Program does not have a fixed expiration date, may be suspended or discontinued at any time, and does not obligate the Company to repurchase any specific dollar amount or to acquire any specific number of shares. The Company may repurchase shares of Class A Common Stock from time to time through open market purchases, in privately negotiated transactions, or by other means, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), in accordance with applicable securities laws and other restrictions. The timing, manner, price, and amount of any repurchases will be determined by the Company at its discretion and will depend on a variety of factors, including business, economic and market conditions, prevailing stock prices, corporate and regulatory requirements, and other considerations.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Basis of preparation	The accompanying condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). These principles are established primarily by the Financial Accounting Standards Board (“FASB”). Due to rounding, numbers presented throughout this document may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.
Principles of consolidation	The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
Use of estimates	The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions in the Company’s condensed consolidated financial statements. These estimates are based on information available as of the date of the condensed consolidated financial statements. On a regular basis, management evaluates these estimates and assumptions. Such management estimates and assumptions include, but are not limited to, revenue recognition, useful lives and impairment of long-lived assets, valuation of intangible assets, fair value measurement of financial instruments and income taxes. Actual results could differ materially from these estimates.
Segment	The Company operates as a single operating segment. An operating segment is defined as a component of an entity for which discrete financial information is available and whose results of operations are regularly reviewed by the chief operating decision maker (“CODM”). The Company’s CODMs are its Co-Chief Executive Officers, who review its results of operations to make decisions about allocating resources and assessing performance based on consolidated financial information. Accordingly, the Company has determined it operates as a single operating and reportable segment.
Foreign currency	The Company’s condensed consolidated financial statements are presented using the U.S. dollar, which is its reporting currency. The functional currency for certain of our foreign subsidiaries is the U.S. dollar, while others use local currencies. The Company translates the foreign functional currency financial statements to U.S. dollars for those entities that do not have the U.S. dollar as their functional currency using the exchange rates at the balance sheet date for assets and liabilities, the period average exchange rates for revenues and expenses, and the historical exchange rates for equity transactions. The effects of foreign currency translation adjustments are recorded in accumulated other comprehensive income in the condensed consolidated statements of comprehensive loss. Foreign currency transaction gains and losses are included in other income (expense), net on the condensed consolidated statements of operations.
Revenue recognition	Policies, Estimates and Judgments Revenues are generally recognized upon the transfer of control of promised products or services provided to customers, reflecting the amount of consideration the Company expects to receive for those products or services. The Company enters into contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. Revenue is recognized net of sales and other similar taxes collected from customers, which are subsequently remitted to governmental authorities. Revenues are recognized upon the application of the following steps: 1. Identification of the contract or contracts with a customer; 2. Identification of the performance obligations in the contract; 3. Determination of the transaction price; 4. Allocation of the transaction price to the performance obligations in the contract; and 5. Recognition of revenue when, or as, the performance obligation is satisfied. The timing of revenue recognition may differ from the timing of billing our customers. The Company receives payments from customers based on a billing schedule as established in its contracts. Contract assets are recognized when performance is completed in advance of billings. Deferred revenue is recorded when billings are in advance of performance under the contract. The Company’s revenue arrangements include standard warranty provisions that the products and services will perform and operate in all material respects with the applicable published specifications, the financial impacts of which have historically been and are expected to continue to be insignificant. The Company’s contracts do not include a significant financing component. Customer contracts often include promises to transfer multiple products and services to a customer. Determining whether products and services are considered distinct performance obligations that should be accounted for separately versus together may require judgment. The Company allocates the transaction price for each contract to each performance obligation based on the relative standalone selling price (“SSP”) for each distinct performance obligation. Judgment is required in determining the SSP for each distinct performance obligation. The Company typically determines an SSP range for its products and services, which is reassessed on a periodic basis or when facts and circumstances change. In most cases, the Company is able to determine SSP based on the observable prices of products or services sold separately in comparable circumstances to similar customers. In instances where performance obligations do not have observable standalone sales, the Company utilizes available information that may include market conditions, pricing strategies, the economic life of the software, and other observable inputs to estimate the price that it would charge if the products and services were sold separately. Products are generally sold with a right of return and may include other credits or incentives, and, in certain instances, the Company may estimate customer usage of its services, which are accounted for as variable consideration when determining the amount of revenue to recognize. Returns and credits are estimated at contract inception and updated at the end of each reporting period if additional information becomes available. Variable consideration was not material for the periods presented. Recognition of Revenue Revenue recognized from contracts with customers is disaggregated into categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. The Company reports revenues in three categories: (i) subscription, (ii) maintenance, and (iii) other. In addition, revenue is presented by geographic region and deployment option in Note 14, “ Revenue. ” Subscription Revenues Subscription revenues consist primarily of fees earned from subscription-based arrangements for providing customers the right to use our software in a cloud-based-infrastructure that the Company provides. The Company also sells on-premises term license agreements for its data center products, which are software licensed for a specified period, and includes support and maintenance service that is bundled with the license for the term of the license period. Subscription revenues are driven primarily by the number and size of active licenses, the type of product and the price of the licenses. Subscription-based arrangements generally have a contractual term of one Maintenance Revenues Maintenance revenues represent fees earned from providing customers with unspecified future updates, upgrades and enhancements and technical product support for perpetual license products on an if-and-when-available basis. Maintenance revenue is recognized ratably over the term of the support period. Other Revenues Other revenues primarily include perpetual license revenue and fees received for sales of third-party apps in the Atlassian Marketplace. Technical account management, consulting and training services are also included in other revenues. Perpetual license revenues represent fees earned from the license of software to customers for use on the customer’s premises other than data center products. Software is licensed on a perpetual basis. Perpetual license revenues consist of the revenues recognized from sales of licenses to customers. The Company no longer sells perpetual licenses or upgrades for our Server offerings. The Company typically recognized revenue on the license portion of perpetual license arrangements once the customer obtained control of the license, which is generally upon delivery of the license. Revenue from the sale of third-party apps via Atlassian Marketplace is recognized on the date of product delivery given that all of our obligations have been met at that time and on a net basis the Company functions as the agent in the relationship. Revenue from technical account management is recognized over the time period that the customer has access to the service. Revenue from consulting and training is recognized over time as the services are performed.
Deferred contract acquisition costs	Deferred contract acquisition costs are costs incurred to obtain a contract, if such costs are recoverable, and consist primarily of sales commissions and related payroll taxes. Incremental costs of obtaining a contract are earned on new and expansion contracts which are capitalized and amortized over the average period of benefit that the Company has determined to be four years, which is typically greater than the term of the initial customer contract and reflects the average period of benefit, including anticipated renewals. The Company does not pay sales commissions upon contract renewal. Amortization is commensurate with the pattern of revenue recognition, or when the transfer of control of the related goods or services occurs, over an estimated period of benefit of four years. Therefore, a portion of commissions related to our data center offering is expensed when the control of the license is transferred to the customer, and all other commissions are amortized on a straight-line basis over the four-year period.The Company determines the period of benefit for commissions paid for the acquisition of the initial customer contract by taking into consideration the initial estimated customer life and the technological life of our unified communications platform and related significant features. The Company includes the deferred contract costs in prepaid expense and other current assets and other non-current assets on the condensed consolidated balance sheets and amortization of deferred contract acquisition costs in marketing and sales expense in the condensed consolidated statements of operations.
Cash, Cash Equivalents and Restricted Cash	Cash and cash equivalents consist of highly liquid investments with an original maturity of three months or less at the date of purchase. Cash equivalents also include amounts due from third-party credit card processors as they are both short-term and highly liquid in nature and are typically converted to cash within three days of the sales transaction. Cash and cash equivalents are stated at fair value.
Accounts receivable, net	The Company records trade accounts receivable at the invoice value, and such receivables are non-interest bearing. The Company considers receivables past due based on the contractual payment terms. The Company makes estimates of expected credit and collectability trends for the allowance for credit losses based on an assessment of various factors, including historical credit loss experience adjusted for forward-looking factors specific to the debtors and the economic environment that may affect our ability to collect from customers.
Fair value measurements	Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy prioritizes the quality and reliability of the information used to determine fair values. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories of inputs: • Level 1 - Quoted (unadjusted) market prices in active markets for identical assets or liabilities; • Level 2 - Observable inputs (other than Level 1 prices) such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; • Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or examination.
Marketable Debt Securities	The Company classifies all marketable debt securities that have original stated maturities of greater than three months as marketable securities on our condensed consolidated balance sheets. The Company determines the appropriate classification of its investments in marketable debt securities at the time of purchase and reevaluates such designation at each balance sheet date. The Company has classified and accounted for its marketable debt securities as available-for-sale (“AFS”). After consideration of its risk versus reward objectives, as well as its liquidity requirements, the Company may sell these debt securities prior to their stated maturities. The Company considers all of our marketable securities as funds available for use in current operations, including those with maturity dates beyond one year, and therefore classifies these securities as current assets on the condensed consolidated balance sheets. The Company evaluates AFS securities with unrealized loss positions for credit loss by assessing whether the decline in fair value below the amortized cost basis has resulted from a credit loss or other factors, whether the Company expects to recover the entire amortized cost basis of the security, our intent to sell and whether it is more likely than not that the Company will be required to sell the securities before the recovery of their amortized cost basis. The Company carries these securities at fair value, and reports the unrealized gains and losses, net of taxes, as a component of accumulated other comprehensive income except for the changes in allowance for expected credit losses, which are recorded in other income (expense), net. Realized gains and losses are determined based on the specific identification method and are reported in other income (expense), net on the condensed consolidated statements of operations.
Strategic Investments	The Company holds strategic investments in privately held debt and equity securities, as well as publicly held equity securities in which the Company does not have a controlling interest. Investments in privately held debt securities are classified as AFS securities. Investments in publicly held equity securities are recorded at fair value with changes in the fair value of the investments recorded in other income (expense), net in the condensed consolidated statements of operations. Investments in privately held equity securities without readily determinable fair values in which the Company does not own a controlling interest or have significant influence over are measured in accordance with the measurement alternative. In applying the measurement alternative, the carrying value of the investment is measured at cost, less impairment, if any, plus or minus changes resulting from observable price changes from orderly transactions for the identical or a similar investment of the same issuer in the period of occurrence. Changes to the carrying value of these investments are recorded through other income (expense), net on the condensed consolidated statements of operations. In determining adjustments to the carrying value of its strategic invest ments in privately held companies, the Company uses the most recent data available to the Company. Valuations of privately held securities are inherently complex and the determination of whether an orderly transaction is for an identical or similar investment requires judgment. In its evaluation, the Company considers factors such as differences in the rights and preferences of the investments and the extent to which those differences would affect the fair values of those investments. The Company’s impairment analysis encompasses an assessment of both qualitative and quantitative factors including the investee’s financial metrics, market acceptance of the investee’s product or technology, general market conditions and liquidity considerations.
Equity Method Investments	Privately held equity securities in which the Company does not have a controlling financial interest but does exercise significant influence over the investment are accounted for under the equity method. The Company records a proportionate share of the investment’s earnings or losses, and impairment, if any, as a component of other income (expense), net in the condensed consolidated statements of operations. These investments are included in strategic investments in the condensed consolidated balance sheets.
Variable Interest Entities	For entities that meet the definition of a variable interest entity (“VIE”), the Company consolidates those entities when the Company is the primary beneficiary of the entity. The Company is determined to be the primary beneficiary when it possesses both the unilateral power to direct activities that most significantly impact the economic performance of the VIE and the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE. The Company continually evaluates whether it qualifies as the primary beneficiary and reconsiders its determination of whether an entity is a VIE upon reconsideration events.
Derivative financial instruments	The Company enters into foreign exchange forward contracts with the objective to mitigate certain currency risks associated with cost of revenues and operating expenses denominated in foreign currencies. These foreign exchange forward contracts are designated as cash flow hedges. The Company also enters into foreign exchange forward contracts to hedge a portion of certain foreign currency denominated as monetary asse ts and liabilities to reduce the risk that such foreign currency will be adversely affected by changes in exchange rates. The Company uses interest rate swaps to hedge the variability of cash flows in the interest payments associated with its variable-rate debt due to changes in the London inter-bank offered rate (“LIBOR”) based floating interest rate. The interest rate swaps are designated as cash flow hedges and involve interest obligations for U.S. dollar-denominated amounts. T he Company does not enter into derivative instrument transactions for trading or speculative purposes. Hedging derivative instruments are recognized as either assets or liabilities and are measured at fair value. For derivative instruments designated as cash flow hedges, the gains (losses) on the derivatives are initially reported as a component of other comprehensive income and is subsequently recognized in earnings when the hedged exposure is recognized in earnings. For derivative instruments that are not designated as hedges, gains (losses) from changes in fair values are primarily recognized in other income (expense), net. The Company enters into master netting agreements with financial institutions to execute its hedging program. The master netting agreements are with select financial institutions to reduce the Company’s credit risk, as well as to reduce its concentration of risk with any single counterparty. The Company had other derivatives, such as embedded exchange feature of the Notes and Capped Calls. Please see Note 12, “ Debt ” for details. The Notes and Capped Calls were measured at fair value at each reporting date, and gains (losses) from changes in fair values were recognized in other income (expense), net in the consolidated statements of operations. The Company used the Black-Scholes option pricing models to estimate the fair value of the exchange feature of the Notes. Certain inputs used in the model such as stock price volatility requires judgment. The fair value of the Capped Calls was obtained from counterparty banks.
Property and equipment	Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method to allocate the cost over the estimated useful lives.
Leases	The Company determines if an arrangement is or contains a lease at inception. Operating lease right-of-use assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Operating lease liabilities are recognized at the present value of the future lease payments at the lease commencement date. The interest rate used to determine the present value of the future lease payments is the Company’s incremental borrowing rate, whenever the interest rate implicit in the lease agreement is not readily determinable. The Company’s incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments and in economic environments where the leased asset is located. The term of the lease includes the initial period of use of the leased asset plus any options to extend or terminate the lease when it is reasonably certain that the option will be exercised. The Company reassesses the lease term if and when a significant event or change in circumstances occurs. The carrying value of operating right-of-use assets includes the amount of lease liabilities recognized, initial direct cost incurred, and any prepaid lease payments less lease incentives. Lease expense for minimum operating lease payments is recognized on a straight-line basis over the lease term. This straight-line lease expense represents a single lease cost which is comprised of both the interest accretion component related to the lease liability and amortization of the right-of-use assets. The Company’s lease agreements generally contain lease and non-lease components. Lease payments under these lease arrangements are primarily fixed. Non-lease components primarily include payments for maintenance and utilities and are expensed as incurred. The Company applies the short-term lease recognition exemption for short-term leases, which are leases with a lease term of 12 months or less. Payments associated with short-term leases are recognized on a straight-line basis over the lease term. The Company did not have any finance lease arrangements as of December 31, 2022 and June 30, 2022.
Assets held for sale	The Company classifies assets as held for sale when all of the following are met: (i) management has committed to a plan to sell the assets; (ii) the assets are available for immediate sale in their present condition; (iii) an active program to locate a buyer has been initiated; (iv) it is probable that a sale will occur within one year; (v) the assets are being actively marketed for sale at a price that is reasonable in relation to their current fair value; and (vi) it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn. If all held for sale criteria are met, the assets are reclassified and presented separately in the condensed consolidated balance sheets as assets held for sale at the lower of the carrying value or the fair value, less cost to sell, and no longer depreciated or amortized.
Business combinations	The Company allocates the purchase price of acquired companies to the tangible and intangible assets acquired and liabilities assumed, based on their estimated fair values. The excess of the purchase price over the fair values of these identifiable assets and liabilities is recorded as goodwill. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred. The Company uses its best estimates and assumptions to assign fair value to the tangible and intangible assets acquired and liabilities assumed at the acquisition date. Assumptions used to estimate the fair value of the intangible assets include, but are not limited to, revenue growth rates, technology migration curves, customer attrition rates and discount rates. These estimates are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, which may not be later than one year from the acquisition date, the Company may record adjustments to the fair value of these tangible and intangible assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the condensed consolidated statements of operations.
Intangible assets	The Company acquires intangible assets separately or in connection with business combinations. Intangible assets are measured at cost initially. Intangible assets with finite lives are amortized over their estimated useful life using the straight-line method. The amortization expense on intangible assets is recognized in the condensed consolidated statements of operations in the expense category consistent with the function of the intangible asset.
Impairment of long-lived assets	The Company evaluates long-lived assets, including purchased intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. Recoverability is measured by comparing the carrying amount to the future undiscounted cash flows the Company expects the asset to generate. Any excess of the carrying value of the asset above its fair value is recognized as an impairment loss.
Goodwill	Goodwill is the excess of the aggregate of the consideration transferred over the identifiable assets acquired and liabilities assumed.Goodwill is tested for impairment at least annually during the fourth quarter of the Company’s fiscal year and more often if and when circumstances indicate that the carrying value may be impaired. The Company’s reporting unit is at the operating segment level. The Company performs its goodwill impairment test at the level of its operating segment, as there are no levels below the operating segment level for which discrete financial information is prepared and regularly reviewed by the Company’s CODMs. A qualitative assessment is performed to determine whether it is more likely than not that the fair value of its operating segment is less than it’s carrying amount. If the operating segment does not pass the qualitative assessment, the carrying amount of the operating segment, including goodwill, is compared to fair value and goodwill is considered impaired if the carrying value exceeds its fair value. Any excess is recognized as an impairment loss in current period earnings.
Exchangeable Senior Notes	In 2018, the Company, through its subsidiary Atlassian US, Inc., issued exchangeable senior notes due May 1, 2023 (the “Notes”), which were classified as financial liabilities at amortized cost and measured using the effective interest rate (“EIR”) method. Amortized cost was calculated by taking into account any discount and issuance cost that were an integral part of the EIR. The EIR amortization was includ ed as interest expense in the condensed consolidated statements of operations. In connection with the issuance of the Notes, the Company entered into privately negotiated capped call transactions (the “Capped Calls”) with certain financial institutions. The capped call transactions were scheduled to expire in May 2023 and were required to be settled in cash. As of June 30, 2022 the Notes and Capped Calls had been fully settled and are no longer outstanding. Refer to Note 12, “ Debt
Stock-based compensation	The Company recognizes compensation expense related to all stock-based awards, including restricted stock units (“RSU”), restricted stock awards and stock options issued to our employees in exchange for their service, based on the estimated fair value of the awards on the grant date. The fair value of each RSU or restricted stock award is based on the fair value of the Company’s common stock on the date of grant. The Company estimated the fair value of stock option awards using the Black-Scholes option pricing model. The Company recognizes costs related to stock-based awards, net of estimated forfeitures, over the awards’ requisite service period on a straight-line basis. The Company estimates forfeitures based on historical experience. The respective expenses are recognized as employee benefits and classified in our condensed consolidated statements of operations according to the activities that the employees perform.
Advertising Costs	Advertising costs are expensed as incurred as a component of marketing and sales expense in the condensed consolidated statements of operations.
Research and development	Research and development costs are expensed as incurred and consists of the employee, software, and hardware costs incurred for the development of new products, enhancements and updates of existing products and quality assurance activities. The costs incurred for the development of the Company’s cloud-based platform and internal use software are evaluated for capitalization during the development phase. No software development costs were capitalized on the Company’s condensed consolidated balance sheet for the periods presented.
Concentration of Credit Risk and Significant Customers	Financial instruments potentially exposing the Company to credit risk consist primarily of cash, cash equivalents, accounts receivable, derivative contracts, investments, and capped call transactions related to our issuance of the Notes. The Company holds cash at financial institutions that management believes are high credit, quality financial institutions and invests in investment grade securities rated A- and above and debt securities. The Company’s derivative contracts expose it to credit risk to the extent that the counterparties may be unable to meet the terms of the arrangement. The Company enters into master netting agreements with select financial institutions to reduce its credit risk and trades with several counterparties to reduce its concentration risk with any single counterparty. The Company does not have significant exposure to counterparty credit risk at this time. In addition, the Company does not require nor is required to post collateral of any kind related to any foreign currency derivatives.Credit risk arising from accounts receivable is mitigated to a certain extent due to our large number of customers and their dispersion across various industries and geographies. The Company’s customer base is highly diversified, thereby limiting credit risk. The Company manages credit risk with customers by closely monitoring its receivables and contract assets. The Company continuously monitors outstanding receivables locally to assess whether there is objective evidence that outstanding accounts receivables and contract assets are credit-impaired.
Income Taxes	The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred income tax assets and liabilities represent temporary differences between the carrying amounts of assets and liabilities in the condensed consolidated financial statements and their corresponding tax basis used in the computation of taxable income. The Company measures deferred tax assets and liabilities using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be reversed. The Company recognizes the effect on deferred tax assets and liabilities of a change in tax rates within the provision for income taxes as expense and income in the period that includes the enactment date. A valuation allowance is established if it is more likely than not that all or a portion of the deferred tax asset will not be realized. Changes in deferred tax assets or liabilities are recognized as a component of benefit from (p rovision for) income taxes in the condensed consolidated statements of operations, except where they relate to items that are recognized in other comprehensive income or directly in equity, in which case the related deferred tax is also recognized in other comprehensive income or equity, respectively. Where deferred tax arises from the initial accounting for a business combination, the tax effect is included in the accounting for the business combination. Deferred tax assets are regularly evaluated for future realization and reduced by a valuation allowance to an amount for which realization is more likely than not. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing temporary differences, projected future taxable income, tax planning strategies, carry back potential if permitted under the tax law, and results of recent operations. Significant management judgment is required to determine the amount of deferred tax assets that can be recognized, based upon the likely timing and the amount of future taxable income, together with future tax-planning strategies. Assumptions about the generation of future taxable income depend on management’s estimates of future cash flows, future business expectations, capital expenditures, dividends, and other capital management transactions. Management judgment is also required in relation to the application of income tax legislation, which involves complexity and an element of uncertainty. In the event there is a change in the Company’s assessment of its ability to recover deferred tax assets, the income tax provision would be adjusted accordingly, resulting in a corresponding adjustment to the condensed consolidated statements of operations.
Recently Adopted Accounting Standards and New Accounting Standards Not Yet Adopted	In March 2020, the FASB issued ASU No. 2020-04, “ Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. ” This ASU is elective and provides relief to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. Optional expedients are provided for contract modification accounting under topics such as debt, leases, and derivatives. The optional amendments were to be effective for all entities as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 through December 31, 2022. In December 2022, the FASB issued ASU No. 2022-06, “Deferral of the Sunset Date of Topic 848,” which deferred the sunset date of Topic 848 from December 31, 2022 to December 31, 2024 to align with the amended cessation date of LIBOR which was delayed to June 30, 2023. The Company is currently evaluating the impact the standard would have on our consolidated financial statements if it chooses to elect to adopt this ASU. In October 2021, the FASB issued ASU No. 2021-08, “Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Topic 805)” . The amendments in this ASU require that an acquirer recognizes and measures contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. This ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years and should be applied prospectively to business combinations occurring on or after the effective date of the amendments. Early adoption is permitted. The Company is currently evaluating the impact of the new guidance on our consolidated financial statements. Recently Adopted Accounting Pronouncements In August 2020, the FASB issued ASU 2020-06, “ Debt–Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging–Contracts in Entity’s Own Equity (Subtopic 815-40) ” to simplify the accounting for convertible instruments and contracts on an entity’s own equity. The Company adopted this standard effective July 1, 2022 using a modified retrospective method. The adoption did not have a material impact on the Company’s condensed consolidated financial statements during the three and six months ended December 31, 2022 .

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Schedule of Estimated Useful Lives	Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method to allocate the cost over the estimated useful lives. The estimated useful lives for each asset class are as follows: Equipment 3 years Computer hardware and computer-related software 3 years Furniture and fittings 5 years Leasehold improvements Shorter of the remaining lease term or 7 years Property and equipment, net consisted of the following (in thousands): December 31, 2022 June 30, 2022 Equipment $ 9,660 $ 9,140 Computer Hardware and Software 27,804 18,324 Furniture and Fittings 24,723 25,157 Leasehold Improvements and Other 128,443 124,758 Property and equipment, gross 190,630 177,379 Less: accumulated depreciation (90,296) (76,717) Property and equipment, net $ 100,334 $ 100,662
Schedule of Estimated Useful Lives for Intangible Assets	The estimated useful lives for each intangible asset class are as follows: Patents, trademarks and other rights 5 - 12 years Customer relationships 3 - 10 years Acquired developed technology 4 - 6 years Intangible assets consisted of the following (in thousands): December 31, 2022 June 30, 2022 Weighted-Average Remaining Useful Lives Acquired Developed Technology $ 234,618 $ 234,618 2 Patents, Trademarks, and Other Rights 33,393 33,393 5 Customer Relationships 129,502 129,502 5 Intangible assets, gross 397,513 397,513 Less: accumulated amortization (313,265) (296,673) Intangible assets, net $ 84,248 $ 100,840

Conversion from IFRS to GAAP (T

Conversion from IFRS to GAAP (Tables)	6 Months Ended
	Dec. 31, 2022
Accounting Changes and Error Corrections [Abstract]
Reconciliation Between IFRS and U.S. GAAP	The reconciliation between IFRS net loss and GAAP net loss for the three and six months ended December 31, 2021 in the Company’s condensed consolidated statements of operations is as follows (in thousands): Three months ended Six months ended Note December 31, 2021 Net loss - IFRS $ (77,472) $ (477,574) Cost of revenues (a), (b) 4,970 6,732 Operating expenses (a), (b) 84,790 99,859 Other expense, net (b), (c) (22,024) (52,895) Interest income (b) (3) (6) Interest expense (b), (d) (14,944) (19,351) Provision for income taxes (e) 2,355 9,703 Net loss - GAAP $ (22,328) $ (433,532) Three Months Ended December 31, 2021 Six Months Ended December 31, 2021 IFRS GAAP IFRS GAAP Net loss per share attributable to ordinary shareholders: Basic and diluted $ (0.31) $ (0.09) $ (1.89) $ (1.72) Conversion adjustments impacting the Company’s condensed consolidated balance sheet as of June 30, 2022, were as follows (in thousands): Note IFRS Adjustments GAAP Assets: Prepaid expenses and other current assets (b) $ 72,303 $ (2,301) $ 70,002 Property and equipment, net (b) 98,554 2,108 100,662 Operating lease right-of-use assets (b) 267,328 9,948 277,276 Goodwill (a) 732,666 (9,828) 722,838 Deferred tax assets (e) 42,760 (32,425) 10,335 Other non-current assets (b) 60,740 (1,878) 58,862 Total conversion adjustments $ (34,376) Liabilities and Stockholders' Equity: Deferred tax liabilities (e) $ 26,457 $ (26,145) $ 312 Common stock and Additional paid in capital (a), (e) 2,710,349 (527,811) 2,182,538 Accumulated other comprehensive income (b), (c), (e) 53,829 (39,965) 13,864 Accumulated deficit (a), (b), (c), (e) (2,428,575) 559,545 (1,869,030) Total conversion adjustments $ (34,376)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2022, by the level within the fair value hierarchy (in thousands): Level 1 Level 2 Total Assets measured at fair value Cash and cash equivalents: Money market funds $ 426,413 $ — $ 426,413 Marketable securities: U.S. treasury securities — 26,069 26,069 Certificates of deposit and time deposits — 10,000 10,000 Derivative financial instruments — 70,514 70,514 Strategic investments: Publicly traded equity securities 19,325 — 19,325 Total assets measured at fair value $ 445,738 $ 106,583 $ 552,321 Liabilities measured at fair value Derivative financial instruments $ — $ 9,537 $ 9,537 Total liabilities measured at fair value $ — $ 9,537 $ 9,537 The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2022, by level within the fair value hierarchy (in thousands): Level 1 Level 2 Total Assets measured at fair value Cash and cash equivalents: Money market funds $ 555,247 $ — $ 555,247 Marketable securities: U.S. treasury securities — 70,294 70,294 Certificates of deposit and time deposits — 3,000 3,000 Derivative financial instruments — 44,052 44,052 Strategic investments: Publicly traded equity securities 30,801 — 30,801 Total assets measured at fair value $ 586,048 $ 117,346 $ 703,394 Liabilities measured at fair value Derivative financial instruments $ — $ 24,100 $ 24,100 Total liabilities measured at fair value $ — $ 24,100 $ 24,100

Investments (Tables)

Investments (Tables)	6 Months Ended
	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Schedule of Available-for-Sale Securities Reconciliation	The Company’s investments of marketable securities as of December 31, 2022, consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. treasury securities $ 26,250 $ — $ (181) $ 26,069 Certificates of deposit and time deposits 10,000 — — 10,000 Total marketable securities $ 36,250 $ — $ (181) $ 36,069 The Company’s investments of marketable securities as of June 30, 2022, consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. treasury securities $ 70,947 $ — $ (653) $ 70,294 Certificates of deposit and time deposits 3,000 — — 3,000 Total marketable securities $ 73,947 $ — $ (653) $ 73,294
Investments Classified by Contractual Maturity Date	The table below summarizes the Company’s marketable securities by remaining contractual maturity based on their effective maturity dates (in thousands): December 31, 2022 June 30, 2022 Due in one year or less $ 36,069 $ 73,294
Schedule of Strategic Investments	Carrying value of privately held debt securities The Company’s investments of privately held debt securities as of December 31, 2022, consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Fair Value Privately held debt securities $ 5,462 $ — $ (3,503) $ 1,959 The Company’s investments of privately held debt securities as of June 30, 2022, consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Fair Value Privately held debt securities $ 5,486 $ — $ (4,218) $ 1,268 as of December 31, 2022 are summarized below (in thousands): Publicly traded equity securities Privately held Total Initial total cost $ 10,270 $ 128,800 $ 139,070 Cumulative net gain (loss) 9,055 (687) 8,368 Carrying Value $ 19,325 $ 128,113 $ 147,438 The carrying values for publicly traded and privately held equity securities as of June 30, 2022 are summarized below (in thousands): Publicly traded equity securities Privately held Total Initial total cost $ 10,270 $ 120,300 $ 130,570 Cumulative net gain 20,531 6,695 27,226 Carrying Value $ 30,801 $ 126,995 $ 157,796
Unrealized Gain (Loss) on Investments	The components of gains and losses on strategic investments were as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Unrealized losses recognized on publicly traded equity securities $ (1,669) $ (22,135) $ (11,477) $ (57,945) Unrealized gains recognized on privately held equity securities 260 — 260 4,388 Unrealized losses recognized on privately held equity securities including impairment (5,927) — (7,642) — Unrealized gains (losses), net $ (7,336) $ (22,135) $ (18,859) $ (53,557) Realized losses on debt securities (212) — (212) — Losses on strategic investments, net $ (7,548) $ (22,135) $ (19,071) $ (53,557) Unrealized gains and losses recognized during the reporting period on privately held equity securities still held at the reporting date $ (5,667) $ — $ (7,382) $ 4,388
Equity Method Investments	The following table sets forth the carrying amounts of the equity method investment and the movements during the six months ended December 31, 2022 (in thousands): Equity Method Investment Balance as of July 20, 2022 $ 88,853 Effect of change in exchange rates (1,069) Balance as of December 31, 2022 $ 87,784

Derivative Contracts (Tables)

Derivative Contracts (Tables)	6 Months Ended
	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Notional Amounts of Outstanding Derivative Positions	The following table sets forth the notional amounts of the Company’s hedging derivative instruments as of December 31, 2022 (in thousands, except for average interest rate): Notional Amounts of Derivative Instruments Notional Amount by Term to Maturity Classification by Notional Amount Under 12 months Over 12 months Total Cash Flow Hedge Non Hedge Total Forward contracts $ 658,857 $ 35,067 $ 693,924 $ 447,419 $ 246,505 $ 693,924 Interest rate swaps: Notional amount $ — $ 650,000 $ 650,000 $ 650,000 $ — $ 650,000 Average interest rate 0.81 % 0.81 % 0.81 % 0.81 % The following table sets forth the notional amounts of the Company’s hedging derivative instruments as of June 30, 2022 (in thousands, except for average interest rate): Notional Amounts of Derivative Instruments Notional Amount by Term to Maturity Classification by Notional Amount Under 12 months Over 12 months Total Cash Flow Hedge Non Hedge Total Forward contracts $ 612,523 $ 37,015 $ 649,538 $ 401,534 $ 248,004 $ 649,538 Interest rate swaps: Notional amount $ — $ 650,000 $ 650,000 $ 650,000 $ — $ 650,000 Average interest rate 0.81 % 0.81 % 0.81 % 0.81 %
Schedule of Fair Value of Derivative Instruments	The fair value of the Company’s derivative instruments were as follows (in thousands): Balance Sheet Location December 31, 2022 June 30, 2022 Derivative assets Derivatives designated as hedging instruments: Foreign exchange forward contracts Prepaid expenses and other current assets $ 6,524 $ — Foreign exchange forward contracts Other non-current assets 1,464 — Interest rate swaps Prepaid expenses and other current assets 25,662 13,296 Interest rate swaps Other non-current assets 34,375 30,367 Derivatives not designated as hedging instruments: Foreign exchange forward contracts Prepaid expenses and other current assets 2,489 389 Total derivative assets $ 70,514 $ 44,052 Derivative liabilities Derivatives designated as hedging instruments: Foreign exchange forward contracts Accrued expenses and other current liabilities $ 9,067 $ 18,208 Foreign exchange forward contracts Other non-current liabilities — 812 Derivatives not designated as hedging instruments: Foreign exchange forward contracts Accrued expenses and other current liabilities 470 5,080 Total derivative liabilities $ 9,537 $ 24,100
Schedule of Pre-Tax Effects of Derivatives Designated as Cash Flow Hedging Instruments	The pre-tax effects of derivatives designated as cash flow hedging instruments on the condensed consolidated financial statements were as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Beginning balance of accumulated gains (losses) in accumulated other comprehensive loss $ 28,471 $ (15,697) $ 24,502 $ (2,936) Gross unrealized gains (losses) recognized in other comprehensive loss 21,881 9,753 22,167 (4,106) Net (gains) losses reclassified from cash flow hedge in accumulated other comprehensive income into profit or loss: Recognized in cost of revenues 611 166 1,125 (14) Recognized in research and development 8,386 1,695 11,865 2,564 Recognized in marketing and sales 366 83 772 38 Recognized in general and administrative 2,149 227 3,730 (102) Recognized in interest expense (4,638) 1,203 (6,935) 1,986 Ending balance of accumulated gains (losses) in accumulated other comprehensive income (loss) $ 57,226 $ (2,570) $ 57,226 $ (2,570)

Property and Equipment (Tables)

Property and Equipment (Tables)	6 Months Ended
	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method to allocate the cost over the estimated useful lives. The estimated useful lives for each asset class are as follows: Equipment 3 years Computer hardware and computer-related software 3 years Furniture and fittings 5 years Leasehold improvements Shorter of the remaining lease term or 7 years Property and equipment, net consisted of the following (in thousands): December 31, 2022 June 30, 2022 Equipment $ 9,660 $ 9,140 Computer Hardware and Software 27,804 18,324 Furniture and Fittings 24,723 25,157 Leasehold Improvements and Other 128,443 124,758 Property and equipment, gross 190,630 177,379 Less: accumulated depreciation (90,296) (76,717) Property and equipment, net $ 100,334 $ 100,662

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	6 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Goodwill consisted of the following (in thousands): Goodwill Balance as of June 30, 2022 $ 722,838 Effect of change in exchange rates 391 Balance as of December 31, 2022 $ 723,229
Schedule of Finite-Lived Intangible Assets	The estimated useful lives for each intangible asset class are as follows: Patents, trademarks and other rights 5 - 12 years Customer relationships 3 - 10 years Acquired developed technology 4 - 6 years Intangible assets consisted of the following (in thousands): December 31, 2022 June 30, 2022 Weighted-Average Remaining Useful Lives Acquired Developed Technology $ 234,618 $ 234,618 2 Patents, Trademarks, and Other Rights 33,393 33,393 5 Customer Relationships 129,502 129,502 5 Intangible assets, gross 397,513 397,513 Less: accumulated amortization (313,265) (296,673) Intangible assets, net $ 84,248 $ 100,840
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	The following tables presents the estimated future amortization expense related to intangible assets held as of December 31, 2022 (in thousands): Fiscal Years: Remainder of 2023 $ 16,310 2024 26,267 2025 14,908 2026 12,370 2027 7,267 Thereafter 7,126 Total future amortization expense $ 84,248

Leases (Tables)

Leases (Tables)	6 Months Ended
	Dec. 31, 2022
Leases [Abstract]
Lease, Cost	The components of lease costs and other information related to leases were as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Operating lease costs $ 13,143 $ 12,824 $ 26,337 $ 24,415 Short-term lease costs 71 110 98 268 Total lease costs $ 13,214 $ 12,934 $ 26,435 $ 24,683 December 31, 2022 June 30, 2022 Weighted average remaining lease term (in years) 8 8 Weighted average discount rate 2.4 % 2.4 % Supplemental cash flow information related to operating leases were as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Cash paid for amounts included in the measurement of operating lease liabilities $ 12,480 $ 11,626 $ 25,662 $ 23,812 Lease liabilities arising from obtaining right-of-use assets and receipt of lease incentive $ — $ 994 $ 11,905 $ 92,743
Lessee, Operating Lease, Liability, Maturity	Future lease payments under non-cancelable operating leases with initial lease terms in excess of one year included in the Company’s lease liabilities as of December 31, 2022 were as follows (in thousands): Fiscal years: Operating Lease Payments Remainder of 2023 $ 27,892 2024 51,351 2025 48,701 2026 41,710 2027 36,755 Thereafter 127,981 Total future operating lease payments 334,390 Less: imputed interest (30,078) Total lease liability balance $ 304,312

Assets Held for Sale (Tables)

Assets Held for Sale (Tables)	6 Months Ended
	Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Major Assets Classified as Held for Sale	The major assets classified as held for sale as of December 31, 2022 and June 30, 2022 were as follows (in thousands): December 31, 2022 June 30, 2022 Cash and cash equivalents $ — $ 2,701 Property and equipment, net $ — $ 57,482

Accrued Expenses and Other Cu_2

Accrued Expenses and Other Current Liabilities (Tables)	6 Months Ended
	Dec. 31, 2022
Other Liabilities Disclosure [Abstract]
Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consist of the following (in thousands): December 31, 2022 June 30, 2022 Accrued expenses $ 115,827 $ 123,381 Employee benefits 126,012 197,701 Tax liabilities 38,011 26,367 Customer deposits 10,131 9,718 Derivative liabilities 9,537 23,288 Liabilities held for sale — 17,564 Other payables 9,412 8,120 Total accrued expenses and other liabilities $ 308,930 $ 406,139

Revenue (Tables)

Revenue (Tables)	6 Months Ended
	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue from External Customers by Geographic Areas	The Company’s revenues by geographic region based on end-users who purchased the Company’s products or services are as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Americas United States $ 373,976 $ 304,755 $ 731,724 $ 574,717 Other Americas 55,733 43,501 107,906 82,263 Total Americas $ 429,709 $ 348,256 $ 839,630 $ 656,980 EMEA 343,770 263,695 648,048 498,709 Asia Pacific 99,225 76,575 192,418 146,861 Total revenues $ 872,704 $ 688,526 $ 1,680,096 $ 1,302,550
Revenue from External Customers by Products and Services	The Company’s revenues by deployment options are as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Cloud $ 512,335 $ 364,099 $ 987,378 $ 682,002 Data Center 194,264 139,108 365,492 250,303 Server 106,168 135,519 219,981 275,066 Marketplace and services 59,937 49,800 107,245 95,179 Total revenues $ 872,704 $ 688,526 $ 1,680,096 $ 1,302,550
Contract with Customer, Contract Asset, Contract Liability, and Receivable	The changes in the balances of contract balances are as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Balance, beginning of period $ 1,172,834 $ 911,050 $ 1,182,680 $ 897,595 Additions 973,951 752,954 1,771,497 1,380,433 Revenue (872,704) (688,526) (1,680,096) (1,302,550) Balance, end of period $ 1,274,081 $ 975,478 $ 1,274,081 $ 975,478
Capitalized Contract Cost	The changes in the balances of deferred contract acquisition costs are as follows (in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Balance, beginning of period $ 29,729 $ 10,722 $ 27,141 $ 9,011 Additions 11,286 3,911 16,415 6,637 Amortization expense (3,027) (1,430) (5,568) (2,445) Balance, end of period $ 37,988 $ 13,203 $ 37,988 $ 13,203 Deferred contract acquisition costs included in: Prepaid expenses and other current assets $ 12,466 $ 4,756 Other non-current assets 25,522 8,447 Total $ 37,988 $ 13,203

Stockholder's Equity (Tables)

Stockholder's Equity (Tables)	6 Months Ended
	Dec. 31, 2022
Equity [Abstract]
Schedule of Unvested Restricted Stock Units Roll Forward	A summary of RSU activity for the six months ended December 31, 2022 was as follows (in thousands except share and per share data): Number of Shares Weighted Average Grant Date Fair Value Aggregate Intrinsic Value Balance as of June 30, 2022 6,023,997 $ 257.62 $ 1,128,897 Granted 6,599,428 $ 237.66 Vested (1,344,975) $ 230.99 $ 260,126 Forfeited or cancelled (420,983) $ 270.12 Balance as of December 31, 2022 10,857,467 $ 248.31 $ 1,397,139

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	6 Months Ended
	Dec. 31, 2022
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Net Loss Per Share	The following tables present the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Class A Class B Class A Class B Class A Class B Class A Class B Numerator: Net Loss $ (119,094) $ (85,937) $ (12,413) $ (9,915) $ (126,357) $ (92,415) $ (239,710) $ (193,822) Denominator: Weighted-average shares outstanding, basic and diluted 148,627 107,247 140,629 112,331 147,582 107,938 139,632 112,901 Net loss per share, basic and diluted $ (0.80) $ (0.80) $ (0.09) $ (0.09) $ (0.86) $ (0.86) $ (1.72) $ (1.72)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	otential weighted average dilutive securities that were not included in the dilutive earnings per share calculation because the effect would be anti-dilutive are as follows (shares in thousands): Three Months Ended December 31, Six Months Ended December 31, 2022 2021 2022 2021 Class A Common Stock options — 1 1 1 Class A restricted stock units 9,167 3,036 6,976 3,283 Class A restricted stock awards 17 94 24 113 Total 9,184 3,131 7,001 3,397

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2022	Jun. 30, 2022	Dec. 31, 2021
Product Information [Line Items]
Average period of benefit	4 years
Restricted cash included in other non-current assets	$ 1,354	$ 1,400	$ 675
Minimum
Product Information [Line Items]
Subscription-based arrangements, contractual term	1 month
Maximum
Product Information [Line Items]
Subscription-based arrangements, contractual term	12 months

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Property and Equipment, Estimated Useful Lives (Details)	6 Months Ended
	Dec. 31, 2022
Equipment
Property, Plant and Equipment [Line Items]
Estimated useful lives	3 years
Computer Hardware and Software
Property, Plant and Equipment [Line Items]
Estimated useful lives	3 years
Furniture and Fittings
Property, Plant and Equipment [Line Items]
Estimated useful lives	5 years
Leasehold improvements
Property, Plant and Equipment [Line Items]
Estimated useful lives	7 years

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Estimated Useful Lives for Intangible Asset Classes (Details)	6 Months Ended
	Dec. 31, 2022
Minimum | Patents, trademarks and other rights
Finite-Lived Intangible Assets [Line Items]
Weighted-Average Remaining Useful Lives (Years)	5 years
Minimum | Customer relationships
Finite-Lived Intangible Assets [Line Items]
Weighted-Average Remaining Useful Lives (Years)	3 years
Minimum | Acquired developed technology
Finite-Lived Intangible Assets [Line Items]
Weighted-Average Remaining Useful Lives (Years)	4 years
Maximum | Patents, trademarks and other rights
Finite-Lived Intangible Assets [Line Items]
Weighted-Average Remaining Useful Lives (Years)	12 years
Maximum | Customer relationships
Finite-Lived Intangible Assets [Line Items]
Weighted-Average Remaining Useful Lives (Years)	10 years
Maximum | Acquired developed technology
Finite-Lived Intangible Assets [Line Items]
Weighted-Average Remaining Useful Lives (Years)	6 years

Conversion from IFRS to GAAP -

Conversion from IFRS to GAAP - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Jun. 30, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stock-based compensation, service period			4 years
Decrease in interest expense from the transition from IFRS to U.S. GAAP	$ 7,508	$ 21,022	$ 13,629	$ 32,540
Embedded exchange
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Embedded exchange derivative					$ 177,900
Exchangeable Senior Notes Maturing May 1 2023 | Senior Notes
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Aggregate principal amount					$ 1,000,000
Adjustments
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Decrease in stock-based compensation expense from the transition from IFRS to U.S. GAAP		(91,200)		(109,300)
Decrease in interest expense from the transition from IFRS to U.S. GAAP		(14,944)		(19,351)
Decrease in lease expense from the transition from IFRS to U.S. GAAP		(600)		(1,100)
Increase (decrease) in other expense, net from the transition from IFRS to U.S. GAAP		22,100		53,100
Adjustments | Impact To Leases
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Decrease in interest expense from the transition from IFRS to U.S. GAAP		(1,900)		(3,600)
Adjustments | Impact To Effective Interest Rate
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Decrease in interest expense from the transition from IFRS to U.S. GAAP		$ 16,900		$ 23,000

Conversion from IFRS to GAAP _2

Conversion from IFRS to GAAP - Reconciliation Between IFRS Net Loss and U.S GAAP Net Loss (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022		Dec. 31, 2021
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net loss	$ (205,031)	$ (22,328)	$ (218,772)		$ (433,532)
Cost of revenues	155,945	110,191	295,337	[1],[2]	206,447	[1],[2]
Operating expenses	815,998	555,293	1,518,025		1,016,584
Other income (expense), net	(6,749)	(22,343)	22,540		(478,147)
Interest income	8,963	74	14,106		351
Decrease in interest expense from the transition from IFRS to U.S. GAAP	7,508	21,022	13,629		32,540
Provision for income taxes	$ 100,498	$ 2,079	$ 108,523		$ 2,715
Net loss per share:
Net loss per share, basic (in USD per share)	$ (0.80)	$ (0.09)	$ (0.86)		$ (1.72)
Net loss per share, diluted (in USD per share)	$ (0.80)	$ (0.09)	$ (0.86)		$ (1.72)
IFRS
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net loss		$ (77,472)			$ (477,574)
Net loss per share:
Net loss per share, basic (in USD per share)		$ (0.31)			$ (1.89)
Net loss per share, diluted (in USD per share)		$ (0.31)			$ (1.89)
Adjustments
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cost of revenues		$ 4,970			$ 6,732
Operating expenses		84,790			99,859
Other income (expense), net		(22,024)			(52,895)
Interest income		(3)			(6)
Decrease in interest expense from the transition from IFRS to U.S. GAAP		(14,944)			(19,351)
Provision for income taxes		$ 2,355			$ 9,703
[1]Amounts include amortization of acquired intangible assets, as follows: Cost of revenues $ 5,697 $ 5,599 $ 11,394 $ 11,288 Research and development 93 93 187 187 Marketing and sales 2,506 2,266 5,011 4,537 Cost of revenues $ 18,553 $ 8,453 $ 29,166 $ 14,370 Research and development 169,342 90,120 279,471 154,402 Marketing and sales 38,156 21,873 61,351 36,367 General and administrative 39,734 25,374 69,428 41,588

Conversion from IFRS to GAAP _3

Conversion from IFRS to GAAP - Conversion Adjustments Impacting Consolidated Balance Sheets (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jun. 30, 2022
Assets
Prepaid expenses and other current assets	$ 107,232	$ 70,002
Property and equipment, net	100,334	100,662
Operating lease right-of-use assets	254,811	277,276
Goodwill	723,229	722,838
Deferred tax assets	7,657	10,335
Other non-current assets	71,795	58,862
Total assets	3,614,015	3,326,830
Liabilities and Stockholders' Equity
Deferred tax liabilities	2,489	312
Common stock and Additional paid in capital		2,182,538
Accumulated other comprehensive income	43,516	13,864
Accumulated deficit	(2,087,802)	(1,869,030)
Total liabilities	$ 3,036,523	2,999,458
IFRS
Assets
Prepaid expenses and other current assets		72,303
Property and equipment, net		98,554
Operating lease right-of-use assets		267,328
Goodwill		732,666
Deferred tax assets		42,760
Other non-current assets		60,740
Liabilities and Stockholders' Equity
Deferred tax liabilities		26,457
Common stock and Additional paid in capital		2,710,349
Accumulated other comprehensive income		53,829
Accumulated deficit		(2,428,575)
Adjustments
Assets
Prepaid expenses and other current assets		(2,301)
Property and equipment, net		2,108
Operating lease right-of-use assets		9,948
Goodwill		(9,828)
Deferred tax assets		(32,425)
Other non-current assets		(1,878)
Total assets		(34,376)
Liabilities and Stockholders' Equity
Deferred tax liabilities		(26,145)
Common stock and Additional paid in capital		(527,811)
Accumulated other comprehensive income		(39,965)
Accumulated deficit		559,545
Total liabilities		$ (34,376)

Fair Value Measurements - Asset

Fair Value Measurements - Assets and Liabilities Measured at Fair Value (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jun. 30, 2022
Liabilities measured at fair value
Derivative financial instruments	$ 9,537	$ 23,288
U.S. treasury securities
Assets measured at fair value
Marketable debt securities	26,069	70,294
Certificates of deposit and time deposits
Assets measured at fair value
Marketable debt securities	10,000	3,000
Fair Value, Recurring
Assets measured at fair value
Current derivative assets	70,514	44,052
Publicly traded equity securities	19,325	30,801
Total assets measured at fair value	552,321	703,394
Liabilities measured at fair value
Derivative financial instruments	9,537	24,100
Total liabilities measured at fair value	9,537	24,100
Fair Value, Recurring | U.S. treasury securities
Assets measured at fair value
Marketable debt securities	26,069	70,294
Fair Value, Recurring | Certificates of deposit and time deposits
Assets measured at fair value
Marketable debt securities	10,000	3,000
Fair Value, Recurring | Money market funds
Assets measured at fair value
Cash and cash equivalents	426,413	555,247
Fair Value, Recurring | Level 1
Assets measured at fair value
Current derivative assets	0	0
Publicly traded equity securities	19,325	30,801
Total assets measured at fair value	445,738	586,048
Liabilities measured at fair value
Derivative financial instruments	0	0
Total liabilities measured at fair value	0	0
Fair Value, Recurring | Level 1 | U.S. treasury securities
Assets measured at fair value
Marketable debt securities	0	0
Fair Value, Recurring | Level 1 | Certificates of deposit and time deposits
Assets measured at fair value
Marketable debt securities	0	0
Fair Value, Recurring | Level 1 | Money market funds
Assets measured at fair value
Cash and cash equivalents	426,413	555,247
Fair Value, Recurring | Level 2
Assets measured at fair value
Current derivative assets	70,514	44,052
Publicly traded equity securities	0	0
Total assets measured at fair value	106,583	117,346
Liabilities measured at fair value
Derivative financial instruments	9,537	24,100
Total liabilities measured at fair value	9,537	24,100
Fair Value, Recurring | Level 2 | U.S. treasury securities
Assets measured at fair value
Marketable debt securities	26,069	70,294
Fair Value, Recurring | Level 2 | Certificates of deposit and time deposits
Assets measured at fair value
Marketable debt securities	10,000	3,000
Fair Value, Recurring | Level 2 | Money market funds
Assets measured at fair value
Cash and cash equivalents	$ 0	$ 0

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - USD ($) $ in Millions	Dec. 31, 2022	Jun. 30, 2022
Fair Value Disclosures [Abstract]
Privately held debt and equity securities and other investments	$ 130.1	$ 128.3

Investments - Schedule of Marke

Investments - Schedule of Marketable Securities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jun. 30, 2022
Marketable Securities
Debt and Equity Securities, FV-NI [Line Items]
Amortized Cost	$ 36,250	$ 73,947
Unrealized Gains	0	0
Unrealized Losses	(181)	(653)
Fair Value	36,069	73,294
U.S. treasury securities
Debt and Equity Securities, FV-NI [Line Items]
Amortized Cost	26,250	70,947
Unrealized Gains	0	0
Unrealized Losses	(181)	(653)
Fair Value	26,069	70,294
Certificates of deposit and time deposits
Debt and Equity Securities, FV-NI [Line Items]
Amortized Cost	10,000	3,000
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	10,000	3,000
Privately Held Debt Securities
Debt and Equity Securities, FV-NI [Line Items]
Amortized Cost	5,462	5,486
Unrealized Gains	0	0
Unrealized Losses	(3,503)	(4,218)
Fair Value	$ 1,959	$ 1,268

Investments - Schedule of Mar_2

Investments - Schedule of Marketable Debt Securities by Remaining Contractual Maturity (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jun. 30, 2022
Investments, Debt and Equity Securities [Abstract]
Due in one year or less	$ 36,069	$ 73,294

Investments - Gains and Losses

Investments - Gains and Losses on Strategic Investments (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Investments, Debt and Equity Securities [Abstract]
Unrealized losses recognized on publicly traded equity securities	$ (1,669)	$ (22,135)	$ (11,477)	$ (57,945)
Unrealized gains recognized on privately held equity securities	260	0	260	4,388
Unrealized losses recognized on privately held equity securities including impairment	(5,927)	0	(7,642)	0
Unrealized gains (losses), net	(7,336)	(22,135)	(18,859)	(53,557)
Realized losses on debt securities	(212)	0	(212)	0
Losses on strategic investments, net	(7,548)	(22,135)	(19,071)	(53,557)
Unrealized gains and losses recognized during the reporting period on privately held equity securities still held at the reporting date	$ (5,667)	$ 0	$ (7,382)	$ 4,388

Investments - Carrying Values f

Investments - Carrying Values for Publicly Traded and Privately Held Equity Securities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jun. 30, 2022
Debt and Equity Securities, FV-NI [Line Items]
Initial total cost	$ 139,070	$ 130,570
Cumulative net gain (loss)	8,368	27,226
Carrying Value	147,438	157,796
Publicly traded equity securities
Debt and Equity Securities, FV-NI [Line Items]
Initial total cost	10,270	10,270
Cumulative net gain (loss)	9,055	20,531
Carrying Value	19,325	30,801
Privately held equity securities
Debt and Equity Securities, FV-NI [Line Items]
Initial total cost	128,800	120,300
Cumulative net gain (loss)	(687)	6,695
Carrying Value	$ 128,113	$ 126,995

Investments - Additional Inform

Investments - Additional Information (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2022	Jul. 20, 2022	Jun. 30, 2022
Debt and Equity Securities, FV-NI [Line Items]
Upward price adjustment	$ 5,500
Downward price adjustment	6,200
Current liabilities	$ (1,644,650)		$ (1,594,056)
Vertical First Trust
Debt and Equity Securities, FV-NI [Line Items]
Retained minority equity interest (as a percentage)		13%
Fair value of retained interest		$ 88,900

Investments - Carrying Amounts

Investments - Carrying Amounts of Equity Method Investments (Details) $ in Thousands	5 Months Ended
	Dec. 31, 2022 USD ($)
Equity Method Investments, Effect Of Foreign Currency Translation [Roll Forward]
Balance as of July 20, 2022	$ 88,853
Effect of change in exchange rates	(1,069)
Balance as of December 31, 2022	$ 87,784

Derivative Contracts - Notional

Derivative Contracts - Notional Amounts of Hedging Derivative Instruments (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jun. 30, 2022
Foreign exchange forward contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	$ 693,924	$ 649,538
Foreign exchange forward contracts | Under 12 months
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	658,857	612,523
Foreign exchange forward contracts | Over 12 months
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	35,067	37,015
Foreign exchange forward contracts | Cash Flow Hedge
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	447,419	401,534
Foreign exchange forward contracts | Non Hedge
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	246,505	248,004
Interest rate swaps
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	$ 650,000	$ 650,000
Average interest rate	0.81%	0.81%
Interest rate swaps | Under 12 months
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	$ 0	$ 0
Interest rate swaps | Over 12 months
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	$ 650,000	$ 650,000
Average interest rate	0.81%	0.81%
Interest rate swaps | Cash Flow Hedge
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	$ 650,000	$ 650,000
Average interest rate	0.81%	0.81%
Interest rate swaps | Non Hedge
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	$ 0	$ 0

Derivative Contracts - Fair Val

Derivative Contracts - Fair Value of Company's Derivative Instruments (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jun. 30, 2022
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative assets	$ 70,514	$ 44,052
Derivative liabilities	9,537	24,100
Prepaid expenses and other current assets | Foreign exchange forward contracts | Cash Flow Hedge
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative assets	6,524	0
Prepaid expenses and other current assets | Foreign exchange forward contracts | Non Hedge
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative assets	2,489	389
Prepaid expenses and other current assets | Interest rate swaps | Cash Flow Hedge
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative assets	25,662	13,296
Other non-current assets | Foreign exchange forward contracts | Cash Flow Hedge
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative assets	1,464	0
Other non-current assets | Interest rate swaps | Cash Flow Hedge
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative assets	34,375	30,367
Accrued expenses and other current liabilities | Foreign exchange forward contracts | Cash Flow Hedge
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative liabilities	9,067	18,208
Accrued expenses and other current liabilities | Foreign exchange forward contracts | Non Hedge
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative liabilities	470	5,080
Other non-current liabilities | Foreign exchange forward contracts | Cash Flow Hedge
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative liabilities	$ 0	$ 812

Derivative Contracts - Pre-Tax

Derivative Contracts - Pre-Tax Effects of Derivatives Designated as Cash Flow Hedging Instruments (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Derivative Instruments, Pre-Tax Effects Of Derivatives Designated As Cash Flow Hedging Instruments [Roll Forward]
Beginning balance of accumulated gains (losses) in accumulated other comprehensive loss	$ 28,471	$ (15,697)	$ 24,502	$ (2,936)
Gross unrealized gains (losses) recognized in other comprehensive loss	21,881	9,753	22,167	(4,106)
Ending balance of accumulated gains (losses) in accumulated other comprehensive income (loss)	57,226	(2,570)	57,226	(2,570)
Recognized in cost of revenues
Derivative Instruments, Pre-Tax Effects Of Derivatives Designated As Cash Flow Hedging Instruments [Roll Forward]
Net (gains) losses reclassified from cash flow hedge in accumulated other comprehensive income into profit or loss:	611	166	1,125	(14)
Recognized in research and development
Derivative Instruments, Pre-Tax Effects Of Derivatives Designated As Cash Flow Hedging Instruments [Roll Forward]
Net (gains) losses reclassified from cash flow hedge in accumulated other comprehensive income into profit or loss:	8,386	1,695	11,865	2,564
Recognized in marketing and sales
Derivative Instruments, Pre-Tax Effects Of Derivatives Designated As Cash Flow Hedging Instruments [Roll Forward]
Net (gains) losses reclassified from cash flow hedge in accumulated other comprehensive income into profit or loss:	366	83	772	38
Recognized in general and administrative
Derivative Instruments, Pre-Tax Effects Of Derivatives Designated As Cash Flow Hedging Instruments [Roll Forward]
Net (gains) losses reclassified from cash flow hedge in accumulated other comprehensive income into profit or loss:	2,149	227	3,730	(102)
Recognized in interest expense
Derivative Instruments, Pre-Tax Effects Of Derivatives Designated As Cash Flow Hedging Instruments [Roll Forward]
Net (gains) losses reclassified from cash flow hedge in accumulated other comprehensive income into profit or loss:	$ (4,638)	$ 1,203	$ (6,935)	$ 1,986

Property and Equipment - Proper

Property and Equipment - Property and Equipment, Net (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jun. 30, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 190,630	$ 177,379
Less: accumulated depreciation	(90,296)	(76,717)
Property and equipment, net	100,334	100,662
Equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	9,660	9,140
Computer Hardware and Software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	27,804	18,324
Furniture and Fittings
Property, Plant and Equipment [Line Items]
Property and equipment, gross	24,723	25,157
Leasehold Improvements and Other
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 128,443	$ 124,758

Property and Equipment - Additi

Property and Equipment - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 7.2	$ 4.3	$ 13.5	$ 9.6

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Schedule of Goodwill (Details) $ in Thousands	6 Months Ended
	Dec. 31, 2022 USD ($)
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 722,838
Effect of change in exchange rates	391
Goodwill, ending balance	$ 723,229

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2022	Jun. 30, 2022
Finite-Lived Intangible Assets [Line Items]
Cost	$ 397,513	$ 397,513
Less: accumulated amortization	(313,265)	(296,673)
Intangible assets, net	84,248	100,840
Acquired developed technology
Finite-Lived Intangible Assets [Line Items]
Cost	$ 234,618	234,618
Weighted-Average Remaining Useful Lives (Years)	2 years
Patents, trademarks and other rights
Finite-Lived Intangible Assets [Line Items]
Cost	$ 33,393	33,393
Weighted-Average Remaining Useful Lives (Years)	5 years
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Cost	$ 129,502	$ 129,502
Weighted-Average Remaining Useful Lives (Years)	5 years

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense for intangible assets	$ 8.3	$ 8	$ 16.6	$ 16

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2023	$ 16,310
2024	26,267
2025	14,908
2026	12,370
2027	7,267
Thereafter	7,126
Total future amortization expense	$ 84,248

Leases - Lease Cost (Details)

Leases - Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Jun. 30, 2022
Leases [Abstract]
Operating lease costs	$ 13,143	$ 12,824	$ 26,337	$ 24,415
Short-term lease costs	71	110	98	268
Total lease costs	$ 13,214	$ 12,934	$ 26,435	$ 24,683
Weighted average remaining lease term (in years)	8 years		8 years		8 years
Weighted average discount rate	2.40%		2.40%		2.40%

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Table (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
Cash paid for amounts included in the measurement of operating lease liabilities	$ 12,480	$ 11,626	$ 25,662	$ 23,812
Lease liabilities arising from obtaining right-of-use assets and receipt of lease incentive	$ 0	$ 994	$ 11,905	$ 92,743

Leases - Future Lease Payments

Leases - Future Lease Payments (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Leases [Abstract]
Remainder of 2023	$ 27,892
2024	51,351
2025	48,701
2026	41,710
2027	36,755
Thereafter	127,981
Total future operating lease payments	334,390
Less: imputed interest	(30,078)
Total lease liability balance	$ 304,312

Leases - Additional Information

Leases - Additional Information (Details) $ in Millions	Dec. 31, 2022 USD ($) extensionOption
Leases [Abstract]
Term of future lease payment	15 years
Number of extension options | extensionOption	2
Length of additional extension periods	10 years
Future lease payments | $	$ 944.6

Assets Held for Sale (Details)

Assets Held for Sale (Details) - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Dec. 31, 2022	Dec. 31, 2022	Jun. 30, 2022	Dec. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain from sale	$ 2,100	$ 45,200
Cash and cash equivalents	1,636,615	1,636,615	$ 1,385,265	$ 899,394
Property and equipment, net	100,334	100,334	100,662
Assets classified as held-for-sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash and cash equivalents	0	0	2,701
Property and equipment, net	$ 0	$ 0	$ 57,482

Accrued Expenses and Other Cu_3

Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jun. 30, 2022
Other Liabilities Disclosure [Abstract]
Accrued expenses	$ 115,827	$ 123,381
Employee benefits	126,012	197,701
Tax liabilities	38,011	26,367
Customer deposits	10,131	9,718
Derivative liabilities	9,537	23,288
Liabilities held for sale	0	17,564
Other payables	9,412	8,120
Total accrued expenses and other liabilities	$ 308,930	$ 406,139

Debt - Exchangeable Senior Note

Debt - Exchangeable Senior Notes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021	Jun. 30, 2018
Debt Instrument [Line Items]
Net loss on exchange derivative and capped call transactions	$ 0	$ 0	$ 0	$ (424,482)
Senior Notes | Exchangeable Senior Notes Maturing May 1 2023
Debt Instrument [Line Items]
Aggregate principal amount					$ 1,000,000
Senior Notes | Exchangeable Senior Notes Maturing May 1 2023 | Capped call transactions
Debt Instrument [Line Items]
Aggregate cost of capped calls					$ 87,700

Debt - Credit Facility (Details

Debt - Credit Facility (Details) - Line of Credit - The Credit Facility $ in Millions	1 Months Ended	6 Months Ended
	Oct. 31, 2020 USD ($)	Dec. 31, 2022 USD ($)
Line of Credit Facility [Line Items]
Obligated repayment amount, as a percentage	1.25%
Debt issuance costs	$ 4.4
Consolidated leverage ratio		3.5
Consolidated leverage ration in event of a material acquisition		4.5
Base Rate
Line of Credit Facility [Line Items]
Variable rate	0.50%
London Interbank Offered Rate (LIBOR) | Minimum
Line of Credit Facility [Line Items]
Variable rate	0.875%
London Interbank Offered Rate (LIBOR) | Maximum
Line of Credit Facility [Line Items]
Variable rate	1.50%
Unsecured Debt
Line of Credit Facility [Line Items]
Borrowing capacity	$ 1,000
Amount drawn		$ 1,000
Commitment fee, as a percentage		0.075%
Revolving Credit Facility
Line of Credit Facility [Line Items]
Borrowing capacity	500
Amount of increase available	$ 250
Commitment fee, as a percentage		0.20%

Commitments - Additional Inform

Commitments - Additional Information (Details) - USD ($) $ in Billions	3 Months Ended	6 Months Ended
	Dec. 31, 2022	Dec. 31, 2022
Long-Term Purchase Commitment [Line Items]
Purchase commitment period	5 years
Purchase commitment, amount	$ 1.9
Minimum
Long-Term Purchase Commitment [Line Items]
Purchase commitment period		1 year
Maximum
Long-Term Purchase Commitment [Line Items]
Purchase commitment period		5 years

Revenue - Remaining Performance

Revenue - Remaining Performance Obligations (Details) $ in Billions	Dec. 31, 2022 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation	$ 1.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percentage	85%
Revenue remaining performance obligation, expected timing of satisfaction period	12 months

Revenue - Disaggregation of Rev

Revenue - Disaggregation of Revenue by Geographic Region and Deployment Options (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Total revenues	$ 872,704	$ 688,526	$ 1,680,096	$ 1,302,550
Cloud
Disaggregation of Revenue [Line Items]
Total revenues	512,335	364,099	987,378	682,002
Data Center
Disaggregation of Revenue [Line Items]
Total revenues	194,264	139,108	365,492	250,303
Server
Disaggregation of Revenue [Line Items]
Total revenues	106,168	135,519	219,981	275,066
Marketplace and services
Disaggregation of Revenue [Line Items]
Total revenues	59,937	49,800	107,245	95,179
Total Americas
Disaggregation of Revenue [Line Items]
Total revenues	429,709	348,256	839,630	656,980
United States
Disaggregation of Revenue [Line Items]
Total revenues	373,976	304,755	731,724	574,717
Other Americas
Disaggregation of Revenue [Line Items]
Total revenues	55,733	43,501	107,906	82,263
EMEA
Disaggregation of Revenue [Line Items]
Total revenues	343,770	263,695	648,048	498,709
Asia Pacific
Disaggregation of Revenue [Line Items]
Total revenues	$ 99,225	$ 76,575	$ 192,418	$ 146,861

Revenue - Additional Informatio

Revenue - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Total revenues	$ 872,704	$ 688,526	$ 1,680,096	$ 1,302,550
Deferred revenue recognized, as a percentage	36%	34%	46%	44%
Premier support
Disaggregation of Revenue [Line Items]
Total revenues	$ 4,600	$ 5,800	$ 9,300	$ 12,000

Revenue - Change in Contract Ba

Revenue - Change in Contract Balances (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Contract With Customer, Liability, Revenue Recognized, Change In Contract Balances [Roll Forward]
Balance, beginning of period	$ 1,172,834	$ 911,050	$ 1,182,680	$ 897,595
Additions	973,951	752,954	1,771,497	1,380,433
Revenue	(872,704)	(688,526)	(1,680,096)	(1,302,550)
Balance, end of period	$ 1,274,081	$ 975,478	$ 1,274,081	$ 975,478

Revenue - Changes in Balance of

Revenue - Changes in Balance of Deferred Commission (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Capitalized Contract Cost [Roll Forward]
Balance, beginning of period	$ 29,729	$ 10,722	$ 27,141	$ 9,011
Additions	11,286	3,911	16,415	6,637
Amortization expense	(3,027)	(1,430)	(5,568)	(2,445)
Balance, end of period	37,988	13,203	37,988	13,203
Deferred contract acquisition costs included in:
Prepaid expenses and other current assets	12,466	4,756	12,466	4,756
Other non-current assets	25,522	8,447	25,522	8,447
Capitalized Contract Cost, Net	$ 37,988	$ 13,203	$ 37,988	$ 13,203

Stockholder's Equity - Addition

Stockholder's Equity - Additional Information (Details) $ / shares in Units, $ in Thousands	1 Months Ended		6 Months Ended
	Apr. 30, 2021	Nov. 30, 2015	Dec. 31, 2022 USD ($) vote $ / shares shares	Dec. 31, 2021 shares	Jun. 30, 2022 USD ($) $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Consent required to convert, percentage			66.66%
Conversion threshold, percentage			10%
Shares available for issuance (in shares)			10,000,000
Shares outstanding (in shares)			0		0
Number of shares available for grant (in shares)			31,899,903
Vesting period		4 years
Restricted Stock Units (RSUs)
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period	4 years	4 years
Cost not yet recognized | $			$ 2,000,000
Cost not yet recognized, period for recognition			2 years
Granted (in shares)			6,599,428
Shares outstanding (in shares)			10,857,467		6,023,997
Aggregate intrinsic value, outstanding | $			$ 1,397,139		$ 1,128,897
Restricted Stock Units (RSUs) | Share-Based Payment Arrangement, Tranche One
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period		1 year
Award vesting rights, percentage		25%
Restricted Stock Units (RSUs) | Share-Based Payment Arrangement, Tranche Two
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period		3 years
Award vesting rights, percentage		8.333%
Class A restricted stock awards
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Granted (in shares)			0	0
Shares outstanding (in shares)			19,929		72,484
Aggregate intrinsic value, outstanding | $			$ 2,600		$ 13,600
Class A
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock, par value (in dollars per share) | $ / shares			$ 0.00001		$ 0.00001
Voting rights, number | vote			1
Class B
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Conversion ratio			1
Common stock, par value (in dollars per share) | $ / shares			$ 0.00001		$ 0.00001
Voting rights, number | vote			10

Stockholder's Equity - Schedule

Stockholder's Equity - Schedule of RSU Activity (Details) - Restricted Stock Units (RSUs) - USD ($) $ / shares in Units, $ in Thousands	6 Months Ended
	Dec. 31, 2022	Jun. 30, 2022
Number of Shares
Beginning balance (in shares)	6,023,997
Granted (in shares)	6,599,428
Vested (in shares)	(1,344,975)
Forfeited or cancelled (in shares)	(420,983)
Ending balance (in shares)	10,857,467
Weighted Average Grant Date Fair Value
Beginning balance (in dollars per share)	$ 257.62
Granted, weighted average grant date fair value (in dollars per share)	237.66
Vested, weighted average grant date fair value (in dollars per share)	230.99
Forfeited or cancelled, weighted average grant date fair value (in dollars per share)	270.12
Ending balance (in dollars per share)	$ 248.31
Aggregate intrinsic value, outstanding	$ 1,397,139	$ 1,128,897
Aggregate intrinsic value, vested	$ 260,126

Net Loss Per Share - Basic and

Net Loss Per Share - Basic and Diluted Net Loss (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Numerator:
Net loss	$ (205,031)	$ (22,328)	$ (218,772)	$ (433,532)
Denominator:
Weighted-average shares outstanding, basic (in shares)	255,874,000	252,960,000	255,520,000	252,533,000
Weighted-average shares outstanding, diluted (in shares)	255,874,000	252,960,000	255,520,000	252,533,000
Net loss per share, basic (in USD per share)	$ (0.80)	$ (0.09)	$ (0.86)	$ (1.72)
Net loss per share, diluted (in USD per share)	$ (0.80)	$ (0.09)	$ (0.86)	$ (1.72)
Class A
Numerator:
Net loss	$ (119,094)	$ (12,413)	$ (126,357)	$ (239,710)
Denominator:
Weighted-average shares outstanding, basic (in shares)	148,627,000	140,629,000	147,582,000	139,632,000
Weighted-average shares outstanding, diluted (in shares)	148,627,000	140,629,000	147,582,000	139,632,000
Net loss per share, basic (in USD per share)	$ (0.80)	$ (0.09)	$ (0.86)	$ (1.72)
Net loss per share, diluted (in USD per share)	$ (0.80)	$ (0.09)	$ (0.86)	$ (1.72)
Class B
Numerator:
Net loss	$ (85,937)	$ (9,915)	$ (92,415)	$ (193,822)
Denominator:
Weighted-average shares outstanding, basic (in shares)	107,247,000	112,331,000	107,938,000	112,901,000
Weighted-average shares outstanding, diluted (in shares)	107,247,000	112,331,000	107,938,000	112,901,000
Net loss per share, basic (in USD per share)	$ (0.80)	$ (0.09)	$ (0.86)	$ (1.72)
Net loss per share, diluted (in USD per share)	$ (0.80)	$ (0.09)	$ (0.86)	$ (1.72)

Net Loss Per Share - Antidiluti

Net Loss Per Share - Antidilutive Securities (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	9,184	3,131	7,001	3,397
Class A Common Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	0	1	1	1
Class A restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	9,167	3,036	6,976	3,283
Class A restricted stock awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities (in shares)	17	94	24	113

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 100,498	$ 2,079	$ 108,523	$ 2,715
Loss before income taxes	(104,533)	$ (20,249)	$ (110,249)	$ (430,817)
Reserve for uncertain tax position	$ 83,000

Subsequent Events (Details)

Subsequent Events (Details) $ in Billions	Jan. 31, 2023 USD ($)
Class A | Subsequent Event
Subsequent Event [Line Items]
Share repurchase program, authorized amount	$ 1